Unspecified acute lower respiratory infection

J10_ACUTELOWERNAS

pneumonia: An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, caused by an infection in one or both of the lungs (by bacteria, viruses, fungi, or mycoplasma.). Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J22 Hospital discharge: ICD-8 — 46699 Cause of death: ICD-10 — J22 Cause of death: ICD-8 — 46699 2 out of 7 registries used, show all original rules.	7085
4. Check minimum number of events None	7085
5. Include endpoints None	7085
6. Filter based on genotype QC (FinnGen only)	6866

Control definitions (FinnGen only)

Control exclude: J10_LOWERINF

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J20-J22
Name in latin: Infectio respiratoria inferior acuta non specificata

NAME	J10_ACUTELOWERNAS
CONTROL_EXCLUDE	J10_LOWERINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J22
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	46699
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J22
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	46699
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Unspecified acute lower respiratory infection based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	70784	28053	42315
Only index persons	58725	22829	35896
Unadjusted period prevalence (%)
Whole population	1.03	0.80	1.18
Only index persons	1.16	0.84	1.37
Median age at first event (years)
Whole population	33.27	52.55	20.18
Only index persons	29.85	45.27	20.03

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6866	2857	4009
Unadjusted period prevalence (%)	1.49	1.01	1.84
Median age at first event (years)	34.24	48.16	24.32

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7084: Matched controls
70839

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

+∞

307.7

2972

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

80.5

307.7

4232

1282

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.5

307.7

2066

7509

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

7.4

307.7

530

761

R03AC02

ATC

salbutamol; inhalant

2.6

307.7

4420

27294

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.2

307.7

1124

3024

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.8

307.7

2810

10546

J45.9

ICD-10 Finland

Asthma, unspecified

3.4

307.7

1900

6874

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

4.4

307.7

1878

5360

R03BB04

ATC

tiotropium bromide; inhalant

3.8

300.7

1054

3141

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.2

298.0

1396

5002

H02AB06

ATC

prednisolone; systemic

2.4

286.0

3800

22841

J01MA14

ATC

moxifloxacin; systemic

3.7

276.9

982

2942

J46

ICD-10 Finland

Status asthmaticus

7.4

267.9

401

572

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.2

257.0

562

1162

49300

ICD-8 Finland

Asthma, bronchiale

6.5

237.5

399

643

R03BA05

ATC

fluticasone; inhalant

2.6

225.6

1578

6931

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

218.9

3445

21427

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.4

217.3

877

2837

C03CA01

ATC

furosemide; systemic

2.3

215.4

2345

12553

R02

ICPC

Shortness of breath/dyspnoea

2.9

211.7

1140

4361

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.7

210.0

511

1152

R06.0

ICD-10 Finland

Dyspnoea

2.3

205.8

2101

10909

R03DC03

ATC

montelukast; oral

2.6

195.7

1375

6012

R50.9

ICD-10 Finland

Fever, unspecified

2.6

195.7

1358

5902

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

194.6

1029

3886

J45.1

ICD-10 Finland

Nonallergic asthma

3.6

193.8

686

2034

R03BA02

ATC

budesonide; inhalant

2.5

188.8

1470

6737

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

185.5

912

3303

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.3

175.5

716

2320

I50.9

ICD-10 Finland

Heart failure, unspecified

2.6

172.1

1182

5086

J01MA12

ATC

levofloxacin; systemic

2.4

170.8

1495

7189

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

163.2

1389

6584

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

162.7

3852

26768

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

11.1

158.3

169

156

J45

ICD-10 Finland

Asthma

2.8

155.0

867

3353

48609

ICD-8 Finland

Pneumonia, unspecified

6.2

154.6

271

454

R96

ICPC

Asthma

2.9

150.5

782

2905

R03AC12

ATC

salmeterol; inhalant

4.0

150.4

445

1161

R03DA04

ATC

theophylline; systemic, rectal

3.7

149.6

501

1425

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.9

149.3

341

727

J01FA06

ATC

roxithromycin; oral

1.9

147.2

2837

18211

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.8

145.9

814

3139

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

143.3

1347

6627

J47

ICD-10 Finland

Bronchiectasis

7.1

141.7

217

316

R03BA01

ATC

beclometasone; inhalant

2.4

141.5

1110

5047

J01AA02

ATC

doxycycline; systemic

2.0

133.5

5379

43243

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.3

131.6

518

1634

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

129.2

1569

8502

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.8

126.3

294

636

R81

ICPC

Pneumonia

4.0

122.9

359

926

R03AC03

ATC

terbutaline; inhalant

2.3

120.5

1059

5036

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

4.4

119.5

307

719

I50.0

ICD-10 Finland

Congestive heart failure

2.8

118.7

631

2362

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

114.8

3470

24983

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.4

112.0

427

1318

J45.8

ICD-10 Finland

Mixed asthma

4.2

111.7

305

748

J01CA04

ATC

amoxicillin; systemic

2.0

111.0

5673

47493

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.8

108.7

607

2329

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

108.5

1004

4862

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

6.6

108.2

176

273

48509

ICD-8 Finland

Bronchopneumonia, unspecified

5.9

107.6

195

337

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

104.6

1592

9254

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.4

104.5

391

1192

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.2

102.3

282

696

J96.1

ICD-10 Finland

Chronic respiratory failure

5.0

100.0

218

446

R05

ICPC

Cough

1.9

95.0

1588

9477

H02AB07

ATC

prednisone; oral

2.1

93.9

960

4821

A02BC02

ATC

pantoprazole; systemic

1.7

91.2

4481

35833

XG410

NOMESCO Finland

Flow-volume spirometry

3.4

90.6

342

1047

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

90.3

737

3373

R03AK08

ATC

formoterol and beclometasone; inhalant

3.3

89.7

352

1104

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

89.6

940

4762

R53

ICD-10 Finland

Malaise and fatigue

1.8

88.1

1691

10496

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.9

87.7

261

681

H02AB04

ATC

methylprednisolone; systemic

2.1

87.1

995

5200

A28

ICPC

Limited function/disability NOS

2.0

85.5

1153

6389

R03AC13

ATC

formoterol; inhalant

3.0

85.1

391

1346

C07AB07

ATC

bisoprolol; oral

1.6

82.6

3092

22866

J01DB01

ATC

cefalexin; oral

1.8

82.6

5677

48947

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

9.1

81.0

110

R06.2

ICD-10 Finland

Wheezing

3.1

80.9

363

1232

49099

ICD-8 Finland

Bronchitis, unspecified

5.5

80.4

157

291

N02AA05

ATC

oxycodone; systemic

1.9

80.1

1178

6705

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

79.6

1909

12567

A46

ICD-10 Finland

Erysipelas

2.0

79.6

1055

5799

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.7

79.4

261

730

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

79.2

1154

6546

TGC00

NOMESCO Finland

Bronchial lavation

4.0

78.6

228

584

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

+∞

77.2

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

76.6

435

1677

AA1AD

NOMESCO Finland

CT of head and brain

1.7

76.2

1775

11571

J01MA02

ATC

ciprofloxacin; systemic

1.6

75.5

2591

18640

N02BE01

ATC

paracetamol; systemic, rectal

1.9

75.4

5976

52728

A03

ICPC

Fever

1.9

74.7

1196

6981

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

74.3

943

5099

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.8

73.3

373

1357

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

16.2

71.8

J01FA10

ATC

azithromycin; systemic

1.6

71.7

3718

29321

N03AX16

ATC

[U] pregabalin

1.7

71.7

1511

9559

J01FF01

ATC

clindamycin; systemic

1.7

71.1

1800

11960

N02AX02

ATC

tramadol; systemic, rectal

1.6

71.1

2817

20886

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

2.3

70.7

606

2820

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.4

69.5

256

771

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

69.4

1286

7830

J20

ICD-10 Finland

Acute bronchitis

2.1

69.1

680

3343

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

68.1

1522

9767

R06AE07

ATC

cetirizine; oral

1.6

67.9

2778

20687

N06AX11

ATC

mirtazapine; oral

1.6

67.4

2195

15494

J01FA09

ATC

clarithromycin; systemic

1.6

67.3

1993

13746

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

66.9

1493

9572

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.2

66.5

139

274

R95

ICPC

Chron obstructive pulmonary disease

3.5

66.1

230

668

L28

ICPC

Limited function/disability (L)

1.8

65.7

1110

6566

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

65.6

1810

12253

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

65.0

1471

9457

SPAT1263

SPAT

Sampling

1.6

64.5

2665

19822

R03BB01

ATC

ipratropium bromide; inhalant

3.0

63.6

288

982

N05CF01

ATC

zopiclone; oral

1.6

63.5

2046

14366

SPAT1254

SPAT

Administration of medicine

1.8

63.2

1013

5891

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

62.3

2013

14128

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

62.2

948

5423

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

61.2

2318

16861

N03AX12

ATC

[U] gabapentin; oral

1.8

60.9

1055

6275

A06AD11

ATC

lactulose; oral

1.8

60.6

977

5686

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.4

59.7

216

643

R03BA08

ATC

ciclesonide; inhalant

2.2

59.5

570

2768

L04AA06

ATC

mycophenolic acid; systemic

3.9

59.2

176

459

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

58.2

1372

8885

J96.0

ICD-10 Finland

Acute respiratory failure

4.8

58.1

130

272

R05

ICD-10 Finland

Cough

1.7

57.6

1304

8351

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

57.3

287

1034

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

56.8

1758

12167

Z3231

NOMESCO Finland

Registered nurse

1.6

56.5

1764

12230

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

56.1

360

1471

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

56.0

1697

11683

N05BA01

ATC

diazepam; systemic, rectal

1.8

55.0

846

4842

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

146.2

54.9

127

Kela drug reimbursment

Transplant complication

4.1

54.1

151

376

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

6.4

54.1

143

R42

ICD-10 Finland

Dizziness and giddiness

1.6

53.7

1378

9098

B01AA03

ATC

warfarin; systemic

1.7

53.5

1231

7900

R04.2

ICD-10 Finland

Haemoptysis

2.8

53.5

270

977

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

53.4

574

2909

R11

ICD-10 Finland

Nausea and vomiting

2.1

53.2

578

2940

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

85.1

52.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

52.6

2859

22243

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.8

52.3

277

1028

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

2.6

52.2

318

1267

N05BA04

ATC

oxazepam; oral

1.6

52.1

1602

11035

R29

ICPC

Respiratory symptom/complaint other

2.2

52.1

455

2128

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.3

52.0

198

609

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

51.8

724

4016

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

51.6

1018

6263

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.9

51.2

150

387

N05AA02

ATC

levomepromazine; systemic

2.6

51.0

318

1281

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

3.9

50.6

151

395

N05AH04

ATC

quetiapine; oral

1.7

50.3

1176

7567

J01DA01

ATC

[U] cefalexin

1.5

50.1

3969

33075

R74

ICPC

Upper respiratory infection acute

1.5

49.9

1965

14279

XG466

NOMESCO Finland

Sleep oxymetry

2.9

49.7

243

864

SPAT1301

SPAT

No procedures

1.5

49.1

1899

13739

ZX120

NOMESCO Finland

Intravenous

2.0

49.1

601

3188

R03AK11

ATC

formoterol and fluticasone; inhalant

3.2

48.6

191

599

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

48.4

1131

7270

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

48.2

708

3986

WX892

NOMESCO Finland

Monitored bed care

2.1

48.2

519

2629

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.6

48.2

159

446

R01AD09

ATC

mometasone; nasal

1.5

47.7

2787

21864

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

47.5

491

2450

M04AA01

ATC

allopurinol; systemic

1.8

46.1

847

5096

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

45.9

611

3331

A07AA02

ATC

nystatin; oral

2.3

45.7

370

1676

M79.6

ICD-10 Finland

Pain in limb

1.5

45.5

2506

19392

R60.0

ICD-10 Finland

Localized oedema

1.8

45.5

738

4282

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

45.3

419

2002

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

45.2

1815

13191

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

45.2

192

631

N05CD07

ATC

temazepam; oral

1.8

45.1

720

4155

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

45.1

1498

10455

A02BC01

ATC

omeprazole; systemic

1.5

44.8

1635

11646

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

44.5

429

2083

SPAT1255

SPAT

Intravenous administration of medicine

2.1

44.3

463

2319

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

44.2

653

3680

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

43.8

475

2410

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

43.8

592

3241

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

43.8

824

4987

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

43.6

966

6110

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.3

43.6

333

1471

207

Kela drug reimbursment

Chronic arrhythmias

1.7

43.5

904

5622

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

43.5

421

2048

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.0

43.4

199

683

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

43.0

379

1776

ZXD05

NOMESCO Finland

Urgent procedure

1.5

42.7

1943

14451

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.4

42.7

156

468

R51.80

ICD-10 Finland

Headache

1.7

42.5

941

5948

R4110

NOMESCO Finland

Physiotherapy

1.5

42.5

1666

12024

Z94.2

ICD-10 Finland

Lung transplant status

14.7

42.5

N06AB04

ATC

citalopram; systemic

1.6

42.3

1244

8430

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

42.2

661

3790

J01FA15

ATC

telithromycin; oral

1.9

41.7

606

3396

N05AX08

ATC

risperidone; systemic

1.9

41.7

565

3096

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.4

41.6

289

1224

Z2446

NOMESCO Finland

Social worker

2.0

41.5

451

2290

E0000UV, ,

ATC

1.4

41.2

2515

19736

S97

ICPC

Chronic ulcer skin

2.1

41.2

397

1928

A10AB05

ATC

insulin aspart; parenteral

1.9

41.1

535

2892

G47.3

ICD-10 Finland

Sleep apnoea

1.5

41.0

1452

10246

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

41.0

1310

9041

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

41.0

2643

20939

Z71.8

ICD-10 Finland

Other specified counselling

1.5

41.0

1845

13676

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.7

40.9

132

365

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

40.9

1230

8374

A02BC03

ATC

lansoprazole; oral

1.5

40.7

1676

12203

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

40.6

409

2019

C03DA01

ATC

spironolactone; oral

1.8

40.5

721

4291

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.4

40.3

100

228

SPAT1262

SPAT

Handing over of treatment supplies

1.6

39.4

1058

7008

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

39.4

800

4938

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

39.4

1420

10049

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.7

39.1

197

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

39.0

488

2602

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

38.8

1467

10482

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

38.8

1481

10603

A01

ICPC

Pain general/multiple sites

1.9

38.7

543

3006

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

38.7

1775

13180

R01AD08

ATC

fluticasone; nasal

1.5

38.6

1718

12677

A02BC05

ATC

esomeprazole; systemic

1.4

38.6

2403

18865

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

38.6

535

2951

P01AB01

ATC

metronidazole; oral, rectal

1.4

38.6

2266

17608

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

38.6

796

4933

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.6

38.6

127

356

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

38.2

445

2316

A04

ICPC

Weakness/tiredness general

1.6

37.6

889

5705

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

37.2

2135

16495

B01AB05

ATC

enoxaparin; parenteral

1.5

37.2

1779

13294

SPAT1325

SPAT

Vaccination

1.4

36.7

1912

14511

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

36.7

297

1344

N06AX21

ATC

duloxetine; oral

1.7

36.6

693

4192

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

36.4

892

5770

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

7.5

36.4

R03DC01

ATC

zafirlukast; oral

3.7

36.4

114

309

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

36.3

1629

12018

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

8.0

36.2

SPAT1216

SPAT

Assessment of functional ability

1.6

36.1

877

5663

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

35.8

2483

19790

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.2

35.6

225

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.6

35.4

181

49309

ICD-8 Finland

Asthma, Unspecified

10.1

35.3

N18.8

ICD-10 Finland

Other chronic renal failure

2.8

35.3

178

644

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

35.3

868

5618

M54.5

ICD-10 Finland

Low back pain

1.4

35.3

2161

16854

WX872

NOMESCO Finland

Intensive care

2.1

35.2

346

1691

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

35.2

551

3153

SPAT1229

SPAT

Assessment of need for aid

1.9

35.2

455

2452

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

35.2

1300

9222

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

35.1

335

1619

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

7.0

35.1

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

349.0

35.0

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

34.8

1538

11299

120

Kela drug reimbursment

Hypogammaglobulinaemia

14.0

34.8

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

34.6

697

4287

E86

ICD-10 Finland

Volume depletion

2.7

34.4

182

676

N03AG01

ATC

valproic acid; systemic, rectal

2.0

34.3

388

1996

T90

ICPC

Diabetes non-insulin dependent

1.5

34.3

1355

9737

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

34.2

380

1944

R28

ICPC

Limited function/disability (R)

3.8

34.1

105

281

WX704

NOMESCO Finland

Intubation

1.8

34.0

503

2829

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.7

33.7

630

3794

N05AH03

ATC

olanzapine; systemic

1.9

33.7

414

2193

49308

ICD-8 Finland

Asthma, Alia definita

8.8

33.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

33.6

630

3797

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

33.6

522

2980

46401

ICD-8 Finland

Acute laryngitis and tracheitis, Laryngitis acuta (subglottica)

4.1

33.6

231

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

33.4

271

1228

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.3

33.4

128

396

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

33.4

340

1685

L17

ICPC

Foot/toe symptom/complaint

1.4

33.3

1605

11975

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.8

32.9

156

ZX108

NOMESCO Finland

Inhalation

5.2

32.5

131

SPAT1260

SPAT

Consultation of another employee

1.5

32.3

990

6734

N30.0

ICD-10 Finland

Acute cystitis

1.6

32.3

840

5503

J01EA01

ATC

trimethoprim; systemic

1.5

32.2

1365

9932

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

31.9

320

1576

J05AH02

ATC

oseltamivir; oral

5.4

31.9

115

N06AA09

ATC

amitriptyline; systemic

1.8

31.7

520

3015

N06AB10

ATC

escitalopram; oral

1.5

31.7

1216

8670

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

31.6

1093

7629

A10AE04

ATC

insulin glargine; parenteral

1.7

31.5

608

3692

R03DX07

ATC

roflumilast; oral

12.4

31.5

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

31.5

2217

17622

ZXA05

NOMESCO Finland

Left side

1.5

31.5

1404

10309

B01AF02

ATC

apixaban; oral

1.6

31.4

701

4423

A29

ICPC

General symptom/complaint other

1.6

31.3

719

4569

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

5.2

31.2

121

SPAT1059

SPAT

Spirometry at the office

2.1

31.1

300

1457

I50.1

ICD-10 Finland

Left ventricular failure

2.1

31.0

309

1518

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

31.0

399

2145

AN1

Coronary angiography

1.7

30.9

634

3913

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

30.9

280

1327

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

30.7

293

1417

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

30.6

1047

7287

B34.9

ICD-10 Finland

Viral infection, unspecified

2.5

30.4

199

820

Z51.5

ICD-10 Finland

Palliative care

1.8

30.3

446

2502

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

30.2

214

915

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

30.2

666

4188

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.9

30.2

141

490

C01AA05

ATC

digoxin; systemic

1.8

29.9

477

2743

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

29.9

335

1718

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.7

29.8

156

576

WZC30

NOMESCO Finland

Teaching

1.5

29.8

887

5990

A01AB09

ATC

miconazole; local oral

1.8

29.8

477

2747

Z3226

NOMESCO Finland

Physiotherapist

1.5

29.7

1050

7354

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

29.7

396

2155

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

29.6

628

3910

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

29.4

1171

8401

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.1

29.4

124

407

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

29.2

218

953

A10BA02

ATC

metformin; oral

1.4

29.2

1627

12409

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.6

29.1

152

R03BC01

ATC

cromoglicic acid; inhalant

3.3

29.1

108

328

A10BH05

ATC

linagliptin; oral

2.1

29.0

300

1495

348

Kela drug reimbursment

Roflumilast

10.4

28.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

28.9

528

3158

R55

ICD-10 Finland

Syncope and collapse

1.6

28.8

643

4053

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.8

28.6

146

532

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.0

28.6

342

1793

N06AX16

ATC

venlafaxine; oral

1.6

28.5

798

5311

R13

ICD-10 Finland

Dysphagia

1.9

28.4

389

2134

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

28.4

265

1271

M05BA04

ATC

alendronic acid; oral

1.8

28.3

429

2430

C01DA14

ATC

isosorbide mononitrate; oral

1.5

28.2

893

6106

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.9

28.1

125

ZXA10

NOMESCO Finland

Bilateral

1.5

27.9

1019

7180

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.7

27.6

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

27.6

1367

10201

S06.0

ICD-10 Finland

Concussion

1.6

27.5

649

4146

JN4AD

NOMESCO Finland

Body CT examination

1.7

27.5

547

3345

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

27.5

775

5165

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

27.5

1384

10358

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

27.3

1008

7113

C09AA05

ATC

ramipril; oral

1.4

27.2

1419

10682

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.4

27.2

185

777

D07AA02

ATC

hydrocortisone; topical

1.5

27.2

820

5547

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

27.1

1231

9037

J01DA06

ATC

[U] cefuroxime

1.5

26.9

791

5319

A02BA02

ATC

ranitidine; systemic

1.5

26.8

1062

7596

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

26.8

752

5004

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

26.8

2084

16730

N03AX09

ATC

lamotrigine; oral

2.0

26.7

296

1512

J01FA01

ATC

erythromycin; systemic

1.6

26.7

753

5016

EBA00

NOMESCO Finland

Extraction of tooth

1.3

26.7

2111

16986

N05AH02

ATC

clozapine; systemic

2.7

26.7

144

541

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.8

26.7

136

496

R07.3

ICD-10 Finland

Other chest pain

1.7

26.6

573

3577

N03AE01

ATC

clonazepam; systemic

1.9

26.6

333

1775

S22.3

ICD-10 Finland

Fracture of rib

1.8

26.5

444

2588

L04AD02

ATC

tacrolimus; systemic

3.5

26.5

263

N05AD01

ATC

haloperidol; systemic

2.3

26.4

208

931

UJF32

NOMESCO Finland

Coloscopy

1.4

26.4

1410

10649

I50

ICD-10 Finland

Heart failure

2.4

26.4

184

781

J01DA09

ATC

[U] cefadroxil

1.4

26.4

1531

11726

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

26.4

560

3484

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

26.3

724

4796

R06AX22

ATC

ebastine; oral

1.5

26.2

938

6573

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.6

26.1

133

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

26.1

299

1546

A10AC01

ATC

insulin (human); parenteral

1.7

26.1

466

2768

WX002

NOMESCO Finland

Sedation and analgesia

1.5

26.1

1053

7559

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

26.1

4432

39626

R52.9

ICD-10 Finland

Pain, unspecified

1.7

26.0

540

3341

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

25.7

689

4534

M10.9

ICD-10 Finland

Gout, unspecified

1.8

25.5

408

2346

TK800

NOMESCO Finland

Hemodialysis

2.6

25.5

146

565

JN4BD

NOMESCO Finland

Extensive body CT

1.6

25.4

555

3478

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

25.3

463

2767

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.1

25.3

108

357

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.5

25.3

252

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

25.2

592

3775

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

25.2

182

785

N05AF03

ATC

chlorprothixene; systemic

2.4

25.1

174

737

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

25.1

3450

29906

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

5.5

25.0

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.5

25.0

254

L04AX01

ATC

azathioprine; systemic

2.0

25.0

262

1313

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

24.9

517

3197

R01

ICPC

Pain respiratory system

2.9

24.8

116

404

C01CA24

ATC

epinephrine; parenteral

1.8

24.7

353

1962

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

24.7

211

977

J02AC03

ATC

voriconazole; systemic

10.0

24.7

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

24.7

148

586

R78

ICPC

Acute bronchitis/bronchiolitis

2.8

24.6

125

455

S18

ICPC

Laceration/cut

1.3

24.5

2591

21662

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

24.5

298

1573

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

5.1

24.4

101

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

24.4

441

2628

R05CB01

ATC

acetylcysteine; inhalant, oral

3.2

24.3

303

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

24.3

982

7043

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

4.4

24.3

141

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

24.2

1643

12877

TJD20

NOMESCO Finland

Change of gastrostomy tube

6.0

24.2

N05CF02

ATC

zolpidem; oral

1.5

24.1

954

6812

51899

ICD-8 Finland

Bronchiectasis

9.7

24.1

J01DC02

ATC

cefuroxime; systemic

1.9

24.0

321

1747

L04AX03

ATC

methotrexate; systemic

1.6

24.0

531

3337

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.1

24.0

316

E66.8

ICD-10 Finland

Other obesity

1.9

24.0

308

1655

K78

ICPC

Atrial fibrillation/flutter

1.7

24.0

421

2488

WW200

NOMESCO Finland

Immunization

2.3

23.9

186

829

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.9

23.9

112

391

J02AC01

ATC

fluconazole; systemic

1.3

23.8

1970

15898

SPAT1097

SPAT

Recording of ECG

1.5

23.7

777

5341

D07AC01

ATC

betamethasone; topical

1.3

23.7

2064

16778

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

23.5

387

2244

ZXA00

NOMESCO Finland

Right side

1.4

23.5

1449

11179

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.7

23.5

129

489

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.7

23.5

122

450

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

23.4

490

3034

A07AA09

ATC

vancomycin; oral

3.2

23.4

300

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

23.4

224

1085

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

23.4

477

2935

WYA20

NOMESCO Finland

Home visit

2.8

23.4

119

434

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

23.2

263

1354

GBB00

NOMESCO Finland

Tracheostomy

3.4

23.1

247

L04AD01

ATC

ciclosporin; systemic

2.7

23.1

123

459

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

23.1

171

746

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.1

23.0

308

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

23.0

315

1727

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.8

23.0

182

J01GB01

ATC

tobramycin; inhalant, parenteral

36.4

23.0

SPAT1058

SPAT

PEF monitoring instruction

1.7

22.8

412

2453

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

22.8

568

3672

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

22.8

319

1762

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

22.8

304

1654

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

22.5

1245

9428

E000001, ,

ATC

1.4

22.5

1121

8340

GDG10

NOMESCO Finland

Bilateral transplantation of lung

23.0

22.5

N05AN01

ATC

lithium; oral

2.4

22.5

155

656

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

22.4

467

2888

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

22.4

232

1157

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

22.4

1605

12664

R06AX27

ATC

desloratadine; oral

1.3

22.3

1595

12578

N06AX03

ATC

mianserin; oral

2.0

22.2

262

1368

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.1

22.2

310

R03BC03

ATC

nedocromil; inhalant

1.8

22.1

339

1927

SPAT1240

SPAT

Therapeutic discussion

1.6

22.0

580

3798

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

22.0

533

3424

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

21.8

2782

23732

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

21.8

425

2585

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

21.7

368

2152

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

21.6

534

3444

N05AA01

ATC

chlorpromazine; systemic, rectal

3.0

21.6

325

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

21.6

127

499

L01BA01

ATC

methotrexate; systemic

2.1

21.6

201

964

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

21.6

307

1705

K77

ICPC

Heart failure

2.5

21.5

130

517

H02AB09

ATC

hydrocortisone; systemic

2.4

21.5

152

651

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

21.4

316

1774

B01AC04

ATC

clopidogrel; oral

1.5

21.4

871

6244

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

21.4

240

1233

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

21.3

739

5135

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

21.3

143

598

R01AD58

ATC

fluticasone, combinations; nasal

1.4

21.2

1351

10458

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.0

21.1

241

1245

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

21.1

343

1983

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.1

21.1

144

A10BH01

ATC

sitagliptin; oral

1.6

21.0

512

3291

46309

ICD-8 Finland

Acute tonsillitis, Unspecified

2.0

21.0

227

1150

R03BB07

ATC

umeclidinium bromide; inhalant

3.9

21.0

153

Z50.1

ICD-10 Finland

Other physical therapy

1.9

21.0

286

1567

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

21.0

127

506

B03XA02

ATC

darbepoetin alfa; parenteral

2.5

21.0

127

506

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.1

20.9

J43.9

ICD-10 Finland

Emphysema, unspecified

2.9

20.9

348

N02BF02

ATC

pregabalin; oral

1.8

20.9

317

1796

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

20.7

135

557

N04AA02

ATC

biperiden; systemic

2.6

20.7

122

480

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

20.6

2262

18888

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

20.5

453

2844

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

20.5

919

6705

SPAT1234

SPAT

Support of social functional capacity

1.8

20.5

293

1630

P29

ICPC

Psychological sympt/compl other

1.7

20.4

390

2358

J94.8

ICD-10 Finland

Other specified pleural conditions

2.8

20.4

100

358

C08CA01

ATC

amlodipine; oral

1.3

20.4

2076

17165

XG405

NOMESCO Finland

Education on PEF monitoring

3.0

20.3

310

W19

ICD-10 Finland

Unspecified fall

1.6

20.3

563

3729

S29

ICPC

Skin symptom/complaint other

1.4

20.3

1005

7461

48099

ICD-8 Finland

Viral pneumonia

5.7

20.2

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

20.1

372

2229

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

20.1

1977

16266

L03

ICPC

Low back symptom/complaint

1.3

20.1

1496

11843

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

20.1

340

1989

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

4.0

20.0

145

R4190

NOMESCO Finland

Nutritional therapy

2.0

20.0

228

1177

M05BX04

ATC

denosumab; parenteral

1.9

20.0

273

1496

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

20.0

241

1268

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

20.0

371

2225

R03CC03

ATC

terbutaline; systemic

2.6

20.0

116

453

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

7.0

19.9

N05AX12

ATC

aripiprazole; systemic

1.9

19.9

238

1250

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

19.9

348

2055

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

19.8

282

1566

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

19.8

2089

17338

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

19.6

179

852

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

19.6

692

4822

XQ800

NOMESCO Finland

Prick test

1.7

19.6

390

2384

N06AB03

ATC

fluoxetine; oral

1.5

19.5

633

4337

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

19.4

19.5

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

19.4

558

3724

R01AD01

ATC

beclometasone; nasal

1.4

19.4

838

6067

A04AA01

ATC

ondansetron; systemic, rectal

1.7

19.4

395

2428

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

19.4

302

1725

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

19.3

307

1763

L03AA02

ATC

filgrastim; parenteral

2.2

19.3

156

708

H01

ICPC

Ear pain/earache

1.5

19.2

597

4052

SPAT1251

SPAT

Organisation of medication

2.0

19.2

203

1021

SPAT1252

SPAT

Overall medication plan or its review

1.7

19.2

353

2113

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

19.2

1260

9783

Z00.0

ICD-10 Finland

General medical examination

1.4

19.2

1058

7993

R04

ICPC

Breathing problem other

2.0

19.1

205

1036

D11

ICPC

Diarrhoea

1.5

19.1

636

4378

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

19.1

337

1994

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.8

19.1

270

1498

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.4

19.0

193

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.2

18.9

156

714

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

18.9

115

460

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.2

18.9

164

766

N05AC02

ATC

thioridazine; oral

2.5

18.8

114

455

R03BB06

ATC

glycopyrronium bromide; inhalant

5.8

18.8

SPAT1060

SPAT

Administration of oxygen

5.5

18.8

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

18.8

295

1689

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

15.9

18.7

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

18.7

341

C08CA02

ATC

felodipine; oral

1.6

18.7

484

3154

P03

ICPC

Feeling depressed

1.6

18.7

518

3428

N06AX12

ATC

bupropion; oral

1.6

18.6

408

2555

WX720

NOMESCO Finland

Own respiration

1.8

18.6

272

1523

SPAT1057

SPAT

Peak expiratory flow measurement

2.4

18.6

121

499

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.2

18.6

148

667

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

18.6

241

1300

K02.1

ICD-10 Finland

Caries of dentine

1.3

18.6

3572

31765

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.8

18.4

297

1713

318

Kela drug reimbursment

Teriparatide

5.2

18.4

M48.0

ICD-10 Finland

Spinal stenosis

1.5

18.4

603

4139

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

5.5

18.3

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

18.3

1258

9827

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.9

18.3

307

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

18.2

196

992

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.4

18.2

122

510

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

4.6

18.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

18.1

243

1325

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

18.1

300

1744

3AC01, ,

NOMESCO Finland

3.2

18.1

214

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.9

18.1

138

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

18.0

1046

7961

N07BA03

ATC

varenicline; oral

1.8

18.0

291

1680

J12.8

ICD-10 Finland

Other viral pneumonia

3.4

18.0

190

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.4

18.0

125

532

S76

ICPC

Skin infection other

1.8

17.8

286

1647

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

17.8

4384

39990

U07

ICPC

Urine symptom/complaint other

1.7

17.8

360

2209

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

17.8

796

5796

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.0

17.8

R01AD12

ATC

fluticasone furoate; nasal

1.3

17.8

1732

14190

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

17.8

176

865

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

17.8

404

2554

A11CC03

ATC

alfacalcidol; systemic

2.3

17.8

140

629

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

17.7

325

1944

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

17.7

345

2097

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

3.4

17.7

192

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.3

17.7

197

RF220, ,

NOMESCO Finland

2.9

17.7

296

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.3

17.7

136

605

A10AE05

ATC

insulin detemir; parenteral

1.7

17.6

316

1878

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

17.6

588

4049

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

17.6

411

2614

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

17.6

341

2069

N05AF05

ATC

zuclopenthixol; systemic

3.3

17.6

203

K08.3

ICD-10 Finland

Retained dental root

1.6

17.6

424

2720

ZXE00

NOMESCO Finland

One hour or less

1.3

17.5

2168

18291

A01AB04

ATC

amphotericin B; local oral

1.9

17.5

224

1204

B37.08

ICD-10 Finland

Other candidal stomatitis

3.8

17.5

137

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.3

17.4

199

R79

ICPC

Chronic bronchitis

7.8

17.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.6

17.4

384

WX882

NOMESCO Finland

High dependency care

2.1

17.3

165

800

UGC02

NOMESCO Finland

Rigid bronchoscopy

6.0

17.3

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

17.2

411

2631

SPAT1283

SPAT

Restricted health certificate

1.4

17.2

940

7083

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

17.1

189

966

N02BF01

ATC

gabapentin; oral

1.6

17.1

418

2689

K59.0

ICD-10 Finland

Constipation

1.7

17.1

286

1668

N17

ICPC

Vertigo/dizziness

1.5

17.1

601

4184

C10AA01

ATC

simvastatin; oral

1.3

17.0

2197

18613

ZY010

NOMESCO Finland

Hospital outpatient

1.7

17.0

292

1715

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

31.5

17.0

N06AB06

ATC

sertraline; oral

1.5

17.0

595

4139

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

16.9

204

1075

Z94.0

ICD-10 Finland

Kidney transplant status

2.9

16.9

276

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

16.9

877

6548

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

16.9

264

1509

N02AA01

ATC

morphine; systemic, rectal

2.6

16.9

100

395

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

16.9

393

2499

P01

ICPC

Feeling anxious/nervous/tense

1.5

16.9

616

4319

N19

ICD-10 Finland

Unspecified kidney failure

2.0

16.8

194

1007

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.3

16.8

125

548

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.8

16.8

310

R06AX13

ATC

loratadine; oral

1.4

16.8

773

5654

D07AC13

ATC

mometasone; topical

1.3

16.8

1587

12935

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.6

16.8

SPAT1310

SPAT

Counselling related to known health issue

1.3

16.7

1681

13810

J05AB01

ATC

aciclovir; systemic

1.3

16.7

1111

8626

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

16.6

358

2233

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

16.6

248

1399

GX1K5

NOMESCO Finland

Diffusion capacity

4.3

16.6

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

16.6

207

1104

Z94.1

ICD-10 Finland

Heart transplant status

6.7

16.6

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

16.5

197

1034

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

16.5

257

1468

F21, ,

ICPC

3.3

16.5

191

R33

ICD-10 Finland

Retention of urine

1.6

16.4

431

2818

N05BB01

ATC

hydroxyzine; systemic

1.7

16.4

309

1861

WX730

NOMESCO Finland

Conventional respirator

2.6

16.4

383

M03BX02

ATC

tizanidine; oral

1.2

16.4

3666

32945

N05AB03

ATC

perphenazine; systemic, rectal

1.9

16.4

196

1030

A41.8

ICD-10 Finland

Other specified sepsis

2.4

16.4

110

461

XF404

NOMESCO Finland

Ambulatory ECG

1.5

16.4

449

2965

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

16.4

115

492

C09CA01

ATC

losartan; oral

1.3

16.4

1327

10594

M02AA07

ATC

piroxicam; topical

1.3

16.3

1909

15967

L04AA01

ATC

[U] ciclosporin

2.8

16.3

276

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

16.3

2130

18048

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

16.3

307

1849

J05AB11

ATC

valaciclovir; oral

1.4

16.3

711

5151

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

16.3

291

1728

XW000

NOMESCO Finland

Bone marrow biopsy

1.9

16.3

212

1146

P76

ICPC

Depressive disorder

1.7

16.3

335

2066

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

16.3

482

3238

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

16.3

1058

8184

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

16.2

202

1076

WW500

NOMESCO Finland

Blood transfusion

1.9

16.2

211

1141

H05AA02

ATC

teriparatide; parenteral

5.0

16.2

-1, ,

ICPC

1.9

16.1

195

1029

R03AC19

ATC

olodaterol

4.9

16.1

S80.0

ICD-10 Finland

Contusion of knee

1.6

16.1

384

2457

S06

ICPC

Rash localized

1.7

16.0

283

1677

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

15.9

180

928

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

15.9

356

2242

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

6.2

15.9

R21

ICPC

Throat symptom/complaint

1.3

15.9

1109

8666

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

15.9

246

1404

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.0

15.8

227

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

15.8

381

2443

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

15.8

227

1266

U02

ICPC

Urinary frequency/urgency

1.4

15.8

629

4483

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

15.8

374

2389

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

15.7

228

1275

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

15.7

452

3017

P01BA02

ATC

hydroxychloroquine; oral

1.6

15.7

387

2496

WX722

NOMESCO Finland

PEEP

1.8

15.6

249

1432

M05BA07

ATC

risedronic acid; oral

2.1

15.5

139

658

J37.0

ICD-10 Finland

Chronic laryngitis

2.0

15.5

166

840

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

15.5

270

1593

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.9

15.5

246

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

15.5

2162

18438

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

15.5

2252

19293

K07

ICPC

Swollen ankles/oedema

1.8

15.5

225

1260

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

15.4

437

2907

ZX112

NOMESCO Finland

Subcutaneous

2.3

15.4

117

518

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

15.4

355

2252

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

15.4

1514

12385

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.2

15.4

126

576

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

15.3

1459

11883

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.9

15.3

242

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

15.3

518

3579

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

7.0

15.2

WVA20

NOMESCO Finland

Medicine administration

2.1

15.2

146

710

RD210, ,

NOMESCO Finland

2.3

15.2

109

471

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

15.2

255

1489

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

15.2

560

3933

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.6

15.1

51900

ICD-8 Finland

Other diseases of respiratory system, Atelectasis pulmonis

17.7

15.1

R52.2

ICD-10 Finland

Other chronic pain

1.9

15.1

191

1024

I20.09

ICD-10 Finland

Unstable angina

1.7

15.1

293

1781

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.1

15.1

143

693

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

11.8

15.0

Z72.0

ICD-10 Finland

Tobacco use

2.0

15.0

149

735

N07BB01

ATC

disulfiram; oral

1.7

14.9

274

1640

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

14.9

323

2018

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

5.4

14.9

R03CC02

ATC

salbutamol; systemic

1.7

14.9

262

1550

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

14.9

183

972

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.4

14.9

414

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

2.9

14.9

230

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.5

14.8

361

U04

ICPC

Incontinence urine

1.7

14.8

251

1471

P72

ICPC

Schizophrenia

2.2

14.7

119

541

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

14.7

1418

11561

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

4.9

14.7

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

4.7

14.7

H03AA01

ATC

levothyroxine sodium; systemic

1.3

14.7

1084

8532

SFA10

NOMESCO Finland

One-surface restoration

1.2

14.7

3192

28476

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

14.6

145

714

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

14.6

129

608

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

4.1

14.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

14.6

503

3485

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

14.6

284

1728

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

14.6

484

3330

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.0

14.5

148

737

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

14.2

14.5

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

14.5

125

584

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

3.4

14.5

156

RF210, ,

NOMESCO Finland

2.0

14.4

150

752

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

14.3

357

2307

J01DA08

ATC

[U] cefaclor

1.5

14.3

519

3632

R01AD05

ATC

budesonide; nasal

1.6

14.3

379

2484

J86.9

ICD-10 Finland

Pyothorax without fistula

3.0

14.3

203

R04.0

ICD-10 Finland

Epistaxis

1.5

14.3

389

2565

R83

ICPC

Respiratory infection other

1.3

14.3

1412

11543

C07AB02

ATC

metoprolol; systemic

1.3

14.3

1014

7933

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

14.3

265

1592

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.6

14.2

124

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

14.2

265

1594

SPAT1312

SPAT

General health counselling

1.3

14.2

1680

14036

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

14.1

412

2758

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

14.1

397

2638

L16

ICPC

Ankle symptom/complaint

1.4

14.0

572

4091

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.6

14.0

310

1947

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

4.3

14.0

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.2

14.0

110

495

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.4

14.0

377

N05BE01

ATC

buspirone; oral

1.9

14.0

160

830

R41.0

ICD-10 Finland

Disorientation, unspecified

1.9

14.0

161

837

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

14.0

380

2506

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.1

14.0

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.6

13.9

126

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

13.9

359

2341

M25.5

ICD-10 Finland

Pain in joint

1.3

13.8

1692

14179

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

13.8

825

6291

A97

ICPC

No disease

1.3

13.8

908

7024

L02

ICPC

Back symptom/complaint

1.5

13.8

498

3482

R09

ICPC

Sinus symptom/complaint

1.5

13.8

388

2578

R75

ICPC

Sinusitis acute/chronic

1.7

13.8

229

1335

P06

ICPC

Sleep disturbance

1.4

13.7

597

4320

WX402

NOMESCO Finland

General anaesthesia

1.3

13.7

1130

9019

L20.0

ICD-10 Finland

Besnier prurigo

1.5

13.7

374

2468

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

13.7

3211

28782

L14

ICPC

Leg/thigh symptom/complaint

1.5

13.7

389

2591

S20.2

ICD-10 Finland

Contusion of thorax

1.6

13.7

291

1812

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

+∞

13.5

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

13.4

644

4739

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

13.4

995

7827

R4120

NOMESCO Finland

Occupational therapy

1.6

13.4

341

2215

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.1

13.4

174

R2110

NOMESCO Finland

Giving the first information

1.6

13.4

315

2010

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.3

13.3

102

454

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

13.3

1247

10118

NF3AA

NOMESCO Finland

Femur X-ray examination

2.2

13.3

110

506

T82

ICPC

Obesity

1.8

13.3

198

1119

Z2221

NOMESCO Finland

Medical doctor

1.3

13.2

1460

12081

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.2

13.2

160

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.8

13.2

203

1157

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

13.2

456

3161

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.1

13.2

127

620

UKC02

NOMESCO Finland

Cystoscopy

1.3

13.2

821

6299

P99

ICPC

Psychological disorders other

1.9

13.1

156

820

-1, ,

NOMESCO Finland

1.2

13.1

1863

15858

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

13.0

240

1439

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

13.0

322

2079

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

4.1

13.0

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.8

13.0

196

1112

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

19.0

12.9

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.8

12.8

233

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.6

12.8

273

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.2

12.7

104

476

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.8

12.7

196

1118

G04CA02

ATC

tamsulosin; oral

1.3

12.7

1356

11171

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

12.7

363

2422

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

12.6

532

3829

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

12.6

408

WX290

NOMESCO Finland

Other blockage of nerve

1.2

12.6

2707

23998

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.6

12.6

275

C08CA13

ATC

lercanidipine; oral

1.4

12.6

686

5154

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

1.9

12.6

148

776

F40.2

ICD-10 Finland

Specific (isolated) phobias

3.4

12.6

130

C08DA01

ATC

verapamil; systemic

1.8

12.6

202

1167

R35

ICD-10 Finland

Polyuria

1.5

12.6

346

2289

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

12.6

2030

17500

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.5

12.5

305

I42.8

ICD-10 Finland

Other cardiomyopathies

4.1

12.5

R10.0

ICD-10 Finland

Acute abdomen

1.8

12.5

171

941

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

12.5

158

848

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

12.5

478

3380

XX4BW, ,

NOMESCO Finland

6.2

12.5

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

3.0

12.4

182

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

3.3

12.4

136

602

Kela drug reimbursment

Children's severe malnutrition

5.0

12.4

N05BA12

ATC

alprazolam; oral

1.4

12.4

490

3486

Angiography of the heart and coronary arteries

1.6

12.4

300

1928

P19

ICPC

Drug abuse

2.8

12.3

221

W06

ICD-10 Finland

Fall involving bed

3.1

12.3

162

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

1.9

12.3

147

775

R06AE09

ATC

levocetirizine; oral

1.4

12.3

719

5462

X58

ICD-10 Finland

Exposure to other specified factors

1.3

12.2

791

6098

GX1D5

NOMESCO Finland

Flow volume spirometry

5.8

12.2

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

12.2

445

3117

284

Kela drug reimbursment

Nintedanib and pirfenidone

4.2

12.2

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

12.2

195

1125

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

12.2

113

544

J01XB01

ATC

colistin; inhalant, parenteral

37.6

12.2

R03AC18

ATC

indacaterol; inhalant

3.4

12.2

128

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

12.1

663

4983

A05

ICPC

Feeling ill

1.6

12.1

313

2041

J33.8

ICD-10 Finland

Other polyp of sinus

2.1

12.1

117

572

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.0

12.1

121

599

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.2

12.1

104

486

N06AA12

ATC

doxepin; systemic

1.7

12.1

239

1461

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

12.1

309

2011

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

12.1

219

1309

205

Kela drug reimbursment

Chronic hypertension

1.3

12.1

1380

11454

E87.6

ICD-10 Finland

Hypokalaemia

1.9

12.0

160

873

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

12.0

166

917

N06AB05

ATC

paroxetine; oral

1.6

12.0

295

1903

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

12.0

174

976

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

12.0

188

1079

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.8

12.0

208

R09.1

ICD-10 Finland

Pleurisy

2.2

12.0

424

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

2.9

11.9

181

46104

ICD-8 Finland

Acute sinusitis, Pansinuitis

5.7

11.9

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

11.9

683

5171

RF221, ,

NOMESCO Finland

5.0

11.9

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

2.4

11.9

325

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.1

11.9

107

510

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.8

11.8

165

914

Catheterization and pressure measurement of the left side of the heart

2.3

11.8

394

Y0499

ICD-8 Finland

Investigation of respiratory system

2.7

11.8

226

R52.0

ICD-10 Finland

Acute pain

1.8

11.8

174

980

D01AC02

ATC

miconazole; topical

1.5

11.8

398

2746

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

11.8

477

3406

N03AF02

ATC

oxcarbazepine; oral

1.8

11.8

169

944

-38

ICPC

Other laboratory test NEC

3.1

11.8

161

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

11.8

430

3014

RS220, ,

NOMESCO Finland

2.4

11.7

321

E000003, ,

ATC

1.7

11.7

220

1327

R03BB05

ATC

aclidinium bromide; inhalant

5.1

11.7

D06AX01

ATC

fusidic acid; topical

1.4

11.7

476

3404

H26.3

ICD-10 Finland

Drug-induced cataract

3.6

11.7

107

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

3.0

11.7

162

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

11.7

254

1591

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.7

11.7

222

G44.2

ICD-10 Finland

Tension-type headache

1.4

11.7

652

4917

J01CA08

ATC

pivmecillinam; oral

1.2

11.7

1769

15129

SPAT1360

SPAT

Extensive global examination

1.5

11.6

339

2270

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

11.6

4144

38350

28009

ICD-8 Finland

Iron deficiency anaemias, Unspecified

4.5

11.6

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

11.6

271

1726

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.6

11.6

263

N05BA02

ATC

chlordiazepoxide; systemic

2.0

11.6

129

664

B02AA02

ATC

tranexamic acid; systemic

1.4

11.6

598

4453

-69

ICPC

Other reason for encounter NEC

1.7

11.6

186

1075

A12AA04

ATC

calcium carbonate; oral

2.3

11.5

361

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

2.4

11.5

306

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.1

11.5

148

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

11.5

322

2139

R00.2

ICD-10 Finland

Palpitations

1.5

11.5

352

2383

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

11.5

676

5139

A10AD05

ATC

insulin aspart; parenteral

2.1

11.5

464

R24

ICPC

Haemoptysis

3.3

11.5

123

F05.9

ICD-10 Finland

Delirium, unspecified

2.0

11.4

112

551

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.4

11.4

S19

ICPC

Skin injury other

1.7

11.4

203

1208

L04

ICPC

Chest symptom/complaint

1.6

11.4

297

1942

ZX114

NOMESCO Finland

Intramuscular

2.4

11.4

332

F41.00

ICD-10 Finland

Moderate panic disorder

2.3

11.4

382

U71

ICPC

Cystitis/urinary infection other

1.6

11.4

263

1673

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.0

11.3

165

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.0

11.3

113

560

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

11.3

618

4645

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

11.3

141

755

XQ855, ,

SPAT

2.8

11.3

187

SAA04

NOMESCO Finland

Special examination of mouth

1.6

11.3

273

1755

A11

ICPC

Chest pain NOS

1.5

11.3

390

2706

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

11.3

211

1273

N03AF01

ATC

carbamazepine; oral, rectal

1.6

11.2

246

1544

R07.0

ICD-10 Finland

Pain in throat

1.5

11.2

345

2337

R03

ICPC

Wheezing

2.7

11.2

221

K92.1

ICD-10 Finland

Melaena

1.6

11.2

269

1726

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.4

11.2

322

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

11.2

785

6121

B02.9

ICD-10 Finland

Zoster without complication

1.6

11.2

286

1862

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

11.2

290

1895

C01BD01

ATC

amiodarone; systemic

1.9

11.2

140

751

N06AX26

ATC

vortioxetine; oral

1.5

11.1

373

2571

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.0

11.1

125

646

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

11.1

1761

15114

A02BA03

ATC

famotidine; systemic

1.7

11.1

180

1044

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.0

11.1

124

640

I95.9

ICD-10 Finland

Hypotension, unspecified

2.3

11.1

361

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

3.9

11.1

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

11.1

1163

9549

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

11.1

155

861

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.9

11.0

137

732

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

11.0

121

620

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

5.3

11.0

C08DB01

ATC

diltiazem; oral

1.6

11.0

245

1543

WX702

NOMESCO Finland

Supraglottic ventilation device

1.6

11.0

278

1805

A08

ICPC

Swelling

1.6

11.0

232

1443

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

8.5

11.0

U05

ICPC

Urination problems other

1.6

11.0

235

1468

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.9

10.9

174

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.6

10.9

230

Z28

ICPC

Limited function/disability (Z)

3.3

10.9

117

B01AB04

ATC

dalteparin; parenteral

1.6

10.9

249

1579

S21

ICPC

Skin texture symptom/complaint

1.3

10.9

668

5111

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

10.9

388

2709

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

4.1

10.8

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

10.8

553

4110

S10

ICPC

Boil/carbuncle

1.5

10.8

290

1908

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

3.4

10.8

108

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

2.5

10.8

261

G40

ICD-10 Finland

Epilepsy

2.8

10.8

192

F10.09

ICD-10 Finland

Alcohol intoxication UNS

1.9

10.8

121

626

Z08

ICPC

Social welfare problem

2.3

10.7

322

T89

ICPC

Diabetes insulin dependent

1.6

10.7

220

1360

P74

ICPC

Anxiety disorder/anxiety state

1.7

10.7

204

1237

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

4.6

10.7

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

3.8

10.6

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.5

10.6

257

A27

ICPC

Fear of other disease NOS

1.6

10.6

226

1410

R06.5

ICD-10 Finland

Mouth breathing

1.4

10.6

485

3542

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

10.6

269

1750

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

10.6

261

1687

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

10.5

226

1412

RF120, ,

NOMESCO Finland

2.5

10.5

252

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.8

10.5

141

773

S22

ICPC

Nail symptom/complaint

1.5

10.5

297

1978

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

10.5

389

2735

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

2.2

10.5

370

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

4.0

10.5

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

4.6

10.5

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

3.6

10.4

J20.4

ICD-10 Finland

Acute bronchitis due to parainfluenza virus

110.2

10.4

H02AB02

ATC

dexamethasone; systemic

1.4

10.4

493

3620

L84

ICPC

Back syndrome without radiat pain

1.6

10.4

229

1440

J18

ICD-10 Finland

Pneumonia, organism unspecified

2.7

10.4

190

J04.0

ICD-10 Finland

Acute laryngitis

1.7

10.4

171

997

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

10.4

150

842

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

10.4

174

1020

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.5

10.4

305

2049

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

10.3

226

1419

R50

ICPC

Respiratory, Medication/prescr/renewal

5.1

10.3

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

10.3

180

1067

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

10.3

155

881

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.3

10.3

310

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.0

10.3

153

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

10.2

171

1001

C02AC05

ATC

moxonidine; oral

1.6

10.2

218

1361

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.5

10.2

295

1974

356

Kela drug reimbursment

Nintedanib and pirfenidone

4.0

10.2

RF420, ,

NOMESCO Finland

2.3

10.2

311

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

10.2

222

1393

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

3.5

10.1

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

10.1

309

2091

S01.0

ICD-10 Finland

Open wound of scalp

1.4

10.1

435

3142

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.1

10.1

461

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

10.1

930

7510

XQ845

NOMESCO Finland

Dermatoscopy

2.1

10.1

428

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.9

10.1

121

640

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.1

10.1

468

N03AX14

ATC

levetiracetam; systemic

1.8

10.1

144

806

N18.0

ICD-10 Finland

End-stage renal disease

2.5

10.1

240

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

10.0

239

1532

N01

ICPC

Headache

1.4

10.0

547

4109

R07.1

ICD-10 Finland

Chest pain on breathing

2.2

10.0

377

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

3.5

10.0

X57

ICD-10 Finland

Unspecified privation

1.9

10.0

121

642

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.8

10.0

156

896

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

10.0

540

4051

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.1

10.0

430

U01

ICPC

Dysuria/painful urination

1.5

10.0

320

2188

L04AA13

ATC

[U] leflunomide

2.0

10.0

110

566

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

9.9

459

3357

Z03

ICPC

Housing/neighbourhood problem

3.0

9.9

140

TPH04, ,

SPAT

3.0

9.9

140

B80

ICPC

Iron deficiency anaemia

1.9

9.9

120

637

-50

ICPC

Medication/prescr/renewal

1.7

9.9

192

1170

L05

ICPC

Flank/axilla symptom/complaint

1.5

9.9

289

1938

V03AE01

ATC

polystyrene sulfonate; oral

2.3

9.9

309

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.5

9.9

254

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

9.9

144

811

A03FA02

ATC

cisapride; oral, rectal

1.5

9.9

335

2317

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

9.8

343

2384

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

9.8

295

1990

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.8

9.8

141

790

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

9.8

177

1059

D07AB08

ATC

desonide; topical

1.4

9.8

528

3960

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

4.9

9.8

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

9.8

3925

36428

A34

ICPC

General and Unspecified, Blood test

2.2

9.8

349

L03AA13

ATC

pegfilgrastim; parenteral

1.7

9.7

166

978

E87.5

ICD-10 Finland

Hyperkalaemia

2.1

9.7

428

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

9.7

196

1207

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

9.7

209

1308

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

9.7

1435

12209

N17.8

ICD-10 Finland

Other acute renal failure

2.3

9.7

287

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

2.3

9.7

287

F10.20

ICD-10 Finland

Alcohol dependence currently independent

1.9

9.7

113

593

G04BD11

ATC

fesoterodine; oral

1.9

9.7

124

671

C05AA08

ATC

fluocortolone; rectal, topical

1.3

9.7

678

5284

R99

ICPC

Respiratory disease other

2.0

9.7

476

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

3.8

9.7

TGB20

NOMESCO Finland

Tracheostomy tube replacement

13.4

9.6

C90.0

ICD-10 Finland

Multiple myeloma

2.5

9.6

233

P15

ICPC

Chronic alcohol abuse

1.7

9.6

172

1026

J01CF02

ATC

cloxacillin; systemic

1.9

9.6

113

594

NH1AD

NOMESCO Finland

Ankle and foot CT

1.9

9.6

113

594

XQ848

NOMESCO Finland

Dermatological photography

1.8

9.6

146

832

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.0

9.6

103

525

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

9.6

286

1927

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.0

9.6

106

546

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

9.6

388

2774

N05AC01

ATC

periciazine; systemic

3.7

9.6

SPAT1167

SPAT

Insertion of urinary catheter

1.8

9.5

146

834

K84

ICPC

Heart disease other

1.8

9.5

133

739

ZZA00

NOMESCO Finland

Split skin graft

1.8

9.5

138

776

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

9.5

126

689

S02

ICPC

Pruritus

1.7

9.5

165

977

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.9

9.5

112

590

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.1

9.5

128

B01AB10

ATC

tinzaparin; parenteral

1.4

9.5

451

3316

WX213

NOMESCO Finland

Lower leg blockade

2.6

9.5

200

E000002, ,

ATC

1.3

9.5

543

4112

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

9.4

264

1755

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.6

9.4

204

1279

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

9.4

163

965

R51

ICD-10 Finland

Headache

1.5

9.4

261

1734

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

9.4

105

544

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

9.3

267

1785

XF612

NOMESCO Finland

Measurement of central venous pressure

4.7

9.3

R5110, ,

SPAT

1.5

9.3

290

1974

UJF92

NOMESCO Finland

Capsular endoscopy

1.9

9.3

109

574

WVA20, ,

SPAT

1.8

9.3

129

717

M01AB05

ATC

diclofenac; systemic, rectal

1.2

9.3

3904

36298

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.0

9.2

130

R1260

NOMESCO Finland

Evaluation of communicative skills

2.1

9.2

410

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

9.2

565

4319

L18

ICPC

Muscle pain

1.6

9.2

187

1155

Z00.8

ICD-10 Finland

Other general examinations

1.4

9.2

376

2694

SFA30

NOMESCO Finland

Three-surface restoration

1.2

9.2

2296

20477

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.1

9.2

115

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.0

9.2

136

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

9.2

657

5136

L50.0

ICD-10 Finland

Allergic urticaria

1.8

9.2

123

676

6BA02, ,

NOMESCO Finland

4.1

9.2

TQW80

NOMESCO Finland

Local dermatologic skincare

1.8

9.1

133

749

79399

ICD-8 Finland

Observation, without need for further medical care, Unspecified

2.3

9.1

276

SPAT1053

SPAT

Memory test

1.3

9.1

618

4792

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

2.9

9.1

147

S30.1

ICD-10 Finland

Contusion of abdominal wall

2.2

9.1

333

A99

ICPC

Disease/condition unspecnature/site

1.4

9.1

438

3224

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

3.6

9.1

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

9.1

346

2447

J01XC01

ATC

fusidic acid; systemic

2.3

9.1

302

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.2

9.1

334

P20

ICPC

Memory disturbance

1.3

9.1

600

4638

K28

ICPC

Limited function/disability (K)

1.9

9.1

104

543

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.7

9.1

154

907

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.3

9.1

271

L04AX05

ATC

pirfenidone; oral

4.6

9.0

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

9.0

301

2075

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.0

9.0

454

WX740

NOMESCO Finland

Nitrogen oxide therapy

4.0

9.0

R31

ICD-10 Finland

Unspecified haematuria

1.3

9.0

509

3844

J93.8

ICD-10 Finland

Other pneumothorax

3.4

9.0

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

9.0

195

1223

V03AE02

ATC

sevelamer; oral

3.2

9.0

106

WYA20, ,

SPAT

3.3

9.0

153

Kela drug reimbursment

Lenalidomid

3.3

9.0

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

9.0

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.6

9.0

188

1169

K04

ICPC

Palpitations/awareness of heart

1.6

9.0

230

1500

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.2

9.0

316

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.2

9.0

329

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.9

9.0

104

545

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

9.0

170

1031

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.7

9.0

166

1001

F99

ICD-10 Finland

Mental disorder, not otherwise specified

1.9

8.9

103

539

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.4

8.9

242

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.5

8.9

218

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.5

8.9

218

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.4

8.9

230

ZX120, ,

SPAT

2.5

8.9

224

4222

FHL

Endonasal etmoidectomy

2.9

8.9

133

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

8.9

630

4917

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

1.9

8.9

103

540

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.6

8.9

185

1150

C07AA05

ATC

propranolol; systemic

1.2

8.9

989

8162

L04AX04

ATC

lenalidomide; oral

3.3

8.9

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.7

8.9

140

808

R01AD11

ATC

triamcinolone; nasal

1.4

8.9

403

2941

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.5

8.8

207

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

8.8

210

1347

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

8.8

751

6004

C10AA03

ATC

pravastatin; oral

1.5

8.8

309

2152

F20

ICD-10 Finland

Schizophrenia

2.7

8.8

167

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

8.8

104

549

F60.8

ICD-10 Finland

Other specific personality disorders

2.9

8.8

134

M01AX17

ATC

nimesulide; oral

1.2

8.8

1149

9646

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

8.8

217

1405

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

8.8

156

931

R07

ICPC

Sneezing/nasal congestion

1.5

8.8

303

2105

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

3.3

8.7

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

2.9

8.7

140

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.0

8.7

413

Z29

ICPC

Social problem NOS

1.9

8.7

112

608

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

8.7

506

3840

G04BD07

ATC

tolterodine; oral

1.6

8.7

209

1345

WX419

NOMESCO Finland

Other general anesthesy

2.5

8.7

203

Z75.5

ICD-10 Finland

Holiday relief care

2.7

8.7

174

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

8.7

326

2301

F34.1

ICD-10 Finland

Dysthymia

1.6

8.6

170

1042

GDC00

NOMESCO Finland

Lobectomy of lung

3.1

8.6

109

F61.0

ICD-10 Finland

Mixed personality disorders

2.0

8.6

428

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.9

8.6

497

SBA00

NOMESCO Finland

Microbiological examinations

1.8

8.6

114

625

K12.2

ICD-10 Finland

Cellulitis and abscess of mouth

2.3

8.6

259

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

4.8

8.6

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.9

8.6

105

561

4451

FHL

Guitar cutting

1.8

8.5

133

765

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

8.5

161

976

SFA20

NOMESCO Finland

Two-surface restoration

1.2

8.5

3376

31152

B37.0

ICD-10 Finland

Candidal stomatitis

2.5

8.5

199

D10

ICPC

Vomiting

1.5

8.5

287

1984

38402

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita

2.5

8.5

217

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.0

8.5

403

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

8.5

495

3757

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.9

8.5

106

570

A02BA04

ATC

nizatidine; systemic

1.4

8.5

352

2529

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

2.9

8.5

126

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

6.4

8.5

SPAT1281

SPAT

Other administrative function

1.4

8.5

370

2683

R5599

NOMESCO Finland

Other rehabilitation service

1.8

8.4

131

753

XF622

NOMESCO Finland

Measurement of minute volume of heart

3.9

8.4

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.9

8.4

106

572

K30

ICD-10 Finland

Functional dyspepsia

1.3

8.4

503

3834

ZXD35

NOMESCO Finland

Usual procedure

1.7

8.4

160

973

A98

ICPC

Health maint/preventive medicine

1.3

8.4

6379

62090

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

2.4

8.4

225

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

2.8

8.3

138

Z2221, ,

SPAT

4.9

8.3

JAH00

NOMESCO Finland

Laparotomy

1.7

8.3

132

763

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

8.3

1386

11908

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.7

8.3

138

808

J20.1

ICD-10 Finland

Acute bronchitis due to Haemophilus influenzae

+∞

8.3

QDB10, ,

SPAT

2.0

8.3

400

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.2

8.3

327

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.7

8.3

155

938

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

8.3

156

946

L12

ICPC

Hand/finger symptom/complaint

1.3

8.3

777

6286

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.3

8.3

470

3555

RS230, ,

NOMESCO Finland

3.0

8.3

112

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

2.9

8.3

128

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

8.2

470

3556

ZX100

NOMESCO Finland

Oral

2.1

8.2

328

M75.5

ICD-10 Finland

Bursitis of shoulder

1.8

8.2

107

583

S70.0

ICD-10 Finland

Contusion of hip

1.6

8.2

186

1180

D07AD01

ATC

clobetasol; topical

1.3

8.2

782

6335

UDC00

NOMESCO Finland

Ear microscopy

1.4

8.2

345

2484

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.1

8.2

368

M10.0

ICD-10 Finland

Idiopathic gout

1.6

8.2

169

1048

R05DA01

ATC

ethylmorphine; oral

1.4

8.2

348

2510

W10

ICD-10 Finland

Fall on and from stairs and steps

1.5

8.2

244

1646

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

3.3

8.2

ZYC01, ,

SPAT

1.3

8.2

459

3465

SPAT1243

SPAT

Psychiatric/psychological examination

1.7

8.2

128

738

D21

ICPC

Swallowing problem

2.1

8.2

336

R84

ICPC

Malignant neoplasm bronchus/lung

3.7

8.2

-59

ICPC

Other therap proced/minor surg NEC

1.8

8.1

125

717

S11

ICPC

Skin infection post-traumatic

2.1

8.1

330

SPAT1211

SPAT

Application of soft bandage

1.4

8.1

404

2993

46099

ICD-8 Finland

Acute nasopharyngitis (common cold)

1.9

8.1

100

536

SPAT1272

SPAT

Drug screening

3.6

8.1

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

8.1

356

2584

N05CD02

ATC

nitrazepam; oral

2.1

8.1

377

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

8.1

437

3280

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

8.1

1175

9964

R06AX26

ATC

fexofenadine; oral

1.4

8.1

317

2256

M35.1

ICD-10 Finland

Other overlap syndromes

3.5

8.1

P27.1

ICD-10 Finland

Bronchopulmonary dysplasia originating in the perinatal period

33.4

8.1

R60.1

ICD-10 Finland

Generalized oedema

2.7

8.1

152

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.2

8.1

V03AE03

ATC

lanthanum carbonate; oral

3.4

8.1

ICB01, ,

SPAT

3.0

8.1

119

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

3.0

8.1

119

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

8.0

399

2955

UJD02

NOMESCO Finland

Gastroscopy

1.5

8.0

213

1402

G41.9

ICD-10 Finland

Status epilepticus, unspecified

2.9

8.0

130

N05AB01

ATC

dixyrazine; systemic

2.2

8.0

286

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.2

8.0

312

B05XA03

ATC

sodium chloride; parenteral

22.0

8.0

N06AA10

ATC

nortriptyline; systemic

1.9

8.0

503

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

8.0

461

ICB03, ,

SPAT

3.6

8.0

A01AB10

ATC

natamycin; local oral

1.7

8.0

132

773

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.5

8.0

209

1372

F03

ICD-10 Finland

Unspecified dementia

1.6

8.0

196

1269

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.5

8.0

249

1697

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.7

8.0

138

819

RS222, ,

NOMESCO Finland

2.2

8.0

268

R63.1

ICD-10 Finland

Polydipsia

3.8

8.0

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.5

8.0

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.7

7.9

146

880

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

1.8

7.9

105

576

29999

ICD-8 Finland

Unspecified psychosis

3.4

7.9

R06.4

ICD-10 Finland

Hyperventilation

2.1

7.9

340

A12BA01

ATC

potassium chloride; oral

1.6

7.9

193

1247

Y96.8

ICD-10 Finland

Other type of accident

2.6

7.9

165

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

7.9

184

1176

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.5

7.9

239

1618

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.8

7.9

117

664

L29.8

ICD-10 Finland

Other pruritus

2.2

7.9

301

R07.2

ICD-10 Finland

Precordial pain

1.9

7.9

527

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

7.9

144

867

R5140, ,

SPAT

2.5

7.9

195

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

7.9

129

754

D06

ICPC

Abdominal pain localized other

1.4

7.9

382

2820

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.6

7.8

174

1100

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.7

7.8

135

800

J98.1

ICD-10 Finland

Pulmonary collapse

3.1

7.8

105

XQ858, ,

SPAT

3.6

7.8

329

Kela drug reimbursment

Lenalidomide

3.6

7.8

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

7.8

111

622

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

7.8

352

2566

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.8

7.8

113

637

E000006, ,

ATC

1.4

7.8

291

2052

M05BX03

ATC

strontium ranelate; oral

3.5

7.8

G04BD12

ATC

mirabegron; oral

1.3

7.8

494

3797

C07AA07

ATC

sotalol; systemic

1.6

7.8

167

1047

P28

ICPC

Limited function/disability (P)

2.5

7.8

196

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.9

7.8

494

C10AA05

ATC

atorvastatin; oral

1.2

7.7

2115

18942

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.5

7.7

222

1488

D12

ICPC

Constipation

1.6

7.7

157

972

RS122, ,

NOMESCO Finland

3.9

7.7

D02AE01

ATC

carbamide; topical

1.4

7.7

293

2075

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.6

7.7

158

981

M01AE02

ATC

naproxen; oral, rectal

1.2

7.7

3176

29316

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.4

7.7

222

RS224, ,

NOMESCO Finland

3.1

7.7

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

7.6

340

2474

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

7.6

145

882

48298

ICD-8 Finland

Other bacterial pneumonia, Other

4.5

7.6

79199

ICD-8 Finland

Headache

2.1

7.6

312

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

7.6

693

5583

S09.9

ICD-10 Finland

Unspecified injury of head

2.1

7.6

352

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.3

7.6

254

A49

ICD-10 Finland

Bacterial infection of unspecified site

3.7

7.6

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.6

7.6

184

1188

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.8

7.6

107

599

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

25.0

7.6

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.0

7.6

387

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

3.1

7.5

K92.0

ICD-10 Finland

Haematemesis

1.7

7.5

122

711

315

Kela drug reimbursment

Clopidogrel

2.3

7.5

230

RS221, ,

NOMESCO Finland

2.1

7.5

347

SPAT1336

SPAT

Request for examination

1.6

7.5

165

1041

SPAT1139

SPAT

Nutrition survey

1.6

7.5

149

917

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.3

7.5

237

D11AH01

ATC

tacrolimus; topical

2.4

7.5

206

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.0

7.5

108

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1.6

7.5

158

988

J30.3

ICD-10 Finland

Other allergic rhinitis

1.6

7.5

164

1035

D05AX52

ATC

calcipotriol, combinations; topical

1.4

7.5

263

1836

68409

ICD-8 Finland

Impetigo, Unspecified

7.1

7.5

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

1.8

7.5

544

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

3.0

7.4

103

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

7.4

298

2130

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.7

7.4

118

684

SPAT1101

SPAT

Orthostatic test

1.5

7.4

189

1234

Y6699, ,

ICD-8 Finland

80.2

7.4

N06AG02

ATC

moclobemide; oral

1.6

7.4

186

1211

A10AB01

ATC

insulin (human); parenteral

1.6

7.4

178

1148

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

7.4

387

2892

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.0

7.4

370

B03XA01

ATC

erythropoietin; parenteral

2.4

7.4

189

-62

ICPC

Administrative procedure

1.7

7.4

127

753

R05CA10

ATC

expectorants - combinations

1.9

7.4

510

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

7.4

256

1782

A98

ICD-10 Finland

Other viral haemorrhagic fevers, not elsewhere classified

2.0

7.4

377

IFA99, ,

SPAT

3.4

7.4

TPX15

NOMESCO Finland

Removal of vascular injection port

3.2

7.4

J21.99

ICD-10 Finland

Acute bronchiolitis, unspecified

7.6

7.4

UDM02

NOMESCO Finland

Sinoscopy

1.8

7.4

539

L08

ICPC

Shoulder symptom/complaint

1.2

7.4

1048

8863

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

3.3

7.4

5AB14, ,

NOMESCO Finland

6.0

7.4

G72.8

ICD-10 Finland

Other specified myopathies

2.0

7.4

398

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.2

7.4

258

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.9

7.3

468

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.3

7.3

214

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.1

7.3

337

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

2.6

7.3

154

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

7.3

240

1652

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.6

7.3

180

1166

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.6

7.3

145

892

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.0

7.3

378

QBB10, ,

SPAT

2.4

7.3

190

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

7.3

292

2087

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.0

7.3

XA421

NOMESCO Finland

Nocturnal polygraphy

3.0

7.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.1

7.3

298

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.2

7.3

259

78200

ICD-8 Finland

Symptoms referable to cardiovascular and lymphatic system, Precordial pain

3.6

7.3

ZY010, ,

SPAT

2.1

7.3

318

Z43.0

ICD-10 Finland

Attention to tracheostomy

6.8

7.3

U28

ICPC

Limited function/disability (U)

2.3

7.3

215

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

3.1

7.3

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

7.3

530

4154

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

4.1

7.3

B82

ICPC

Anaemia other/unspecified

1.7

7.3

124

734

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.5

7.3

183

1193

J80

ICD-10 Finland

Adult respiratory distress syndrome

3.5

7.2

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.0

7.2

359

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

7.2

319

2318

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.4

7.2

203

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.7

7.2

138

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

3.3

7.2

J01CF05

ATC

flucloxacillin; systemic

1.4

7.2

297

2133

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

6.2

7.2

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.7

7.2

118

690

T74.1

ICD-10 Finland

Physical abuse

1.8

7.2

521

A10BB12

ATC

glimepiride; oral

1.4

7.2

313

2269

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

4.3

7.2

N06AX05

ATC

trazodone; oral

1.7

7.2

117

683

TK810

NOMESCO Finland

Hemofiltration

2.8

7.2

127

Z09

ICPC

Legal problem

2.8

7.2

127

S01

ICPC

Pain/tenderness of skin

1.5

7.2

202

1348

D11AX14

ATC

[U] tacrolimus

3.0

7.2

100

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.0

7.2

381

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.1

7.2

287

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.6

7.2

156

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

3.9

7.1

RF421, ,

NOMESCO Finland

2.9

7.1

111

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.5

7.1

180

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

7.1

446

3422

M79.7

ICD-10 Finland

Fibromyalgia

1.7

7.1

130

783

S04

ICPC

Lump/swelling localized

1.3

7.1

465

3589

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.6

7.1

156

984

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.2

7.1

255

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

20.0

7.1

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.5

7.1

186

1222

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

7.1

1027

8696

B81

ICPC

Anaemia vit B12/folate deficiency

1.6

7.1

164

1048

K08.80

ICD-10 Finland

Toothache NOS

1.3

7.1

398

3006

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

1.7

7.1

122

724

Y96.9

ICD-10 Finland

Unspecified type of accident

1.9

7.1

474

P17

ICPC

Tobacco abuse

2.1

7.1

315

SPAT1104

SPAT

Monitoring of emergency patient

1.4

7.1

303

2192

M54

ICD-10 Finland

Dorsalgia

1.3

7.1

617

4947

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.8

7.1

532

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

1.9

7.1

432

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

2.5

7.1

169

PAW37

NOMESCO Finland

Biopsy of temporal artery

2.8

7.0

123

S01AD03

ATC

aciclovir; ophthalmic

1.6

7.0

153

964

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.6

7.0

148

925

B35.3

ICD-10 Finland

Tinea pedis

1.5

7.0

211

1428

SPAT1285

SPAT

Provision of consultation response

1.5

7.0

235

1625

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

10.0

7.0

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.1

7.0

316

C09AA02

ATC

enalapril; systemic

1.2

7.0

924

7753

S00.0

ICD-10 Finland

Superficial injury of scalp

1.7

7.0

110

636

NG1DA

NOMESCO Finland

X-ray of knees

1.9

7.0

398

P98

ICPC

Psychosis NOS/other

2.6

7.0

146

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

1.8

7.0

490

R05DB20

ATC

other cough suppressants - combinations

1.5

7.0

242

1684

K43

ICPC

Cardiovascular, Other diagnostic procedure

2.3

7.0

225

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

2.3

7.0

225

XF602

NOMESCO Finland

Bloodpressure monitoring

2.2

7.0

257

47099

ICD-8 Finland

Influenza, unqualified

2.4

7.0

194

SPAT1313

SPAT

Guidance and counselling related to accident prevention

3.1

7.0

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

7.0

493

3847

F03

ICPC

Eye discharge

1.4

7.0

284

2036

H3603, E103,

ICD-10 Finland

2.2

7.0

251

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.5

7.0

180

1180

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.7

7.0

132

804

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

3.4

7.0

N07BC02

ATC

methadone; systemic

3.4

7.0

Z29.0

ICD-10 Finland

Isolation

3.4

7.0

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

3.2

7.0

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

3.3

6.9

UGB02

NOMESCO Finland

Tracheoscopy

4.4

6.9

A06AH03

ATC

naloxegol; oral

2.1

6.9

304

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.0

6.9

372

C09CA06

ATC

candesartan; oral

1.2

6.9

1154

9903

C09DX04

ATC

valsartan and sacubitril; oral

2.3

6.9

220

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.2

6.9

265

D02

ICPC

Abdominal pain epigastric

1.4

6.9

255

1797

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.7

6.9

A10

ICPC

Bleeding/haemorrhage NOS

2.5

6.9

171

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

5.8

6.9

ZY000

NOMESCO Finland

Hospital inpatient

2.1

6.9

305

4732A

ICD-9 Finland

Chronic sinusitis, Ethmoidal

7.5

6.9

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.9

130

791

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.6

6.9

156

993

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

13.8

6.9

RF313, ,

NOMESCO Finland

4.0

6.9

K22.1

ICD-10 Finland

Ulcer of oesophagus

1.9

6.9

422

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.8

6.9

479

KMAK, ,

NOMESCO Finland

1.1

6.9

2865

26391

5BA08, ,

NOMESCO Finland

3.1

6.8

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.4

6.8

190

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

2.4

6.8

178

03400

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Streptococcal sore throat

2.4

6.8

178

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

3.3

6.8

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.2

6.8

228

TAB00

NOMESCO Finland

Lumbar puncture

1.5

6.8

208

1414

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.3

6.8

222

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

6.8

386

2923

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

6.8

1169

10062

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.9

6.8

467

J34.2

ICD-10 Finland

Deviated nasal septum

1.4

6.8

284

2048

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.6

6.8

140

872

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

2.2

6.8

235

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

6.7

254

1797

M03BX01

ATC

baclofen; systemic

1.8

6.7

482

WW409

NOMESCO Finland

Other aferesis

4.3

6.7

Z93.0

ICD-10 Finland

Tracheostomy status

16.7

6.7

F20.0

ICD-10 Finland

Paranoid schizophrenia

2.5

6.7

161

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.4

6.7

357

2675

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

6.7

193

1295

A10BK03

ATC

empagliflozin; oral

1.3

6.7

437

3373

R49.01

ICD-10 Finland

Functional dysphonia

1.7

6.7

125

758

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.6

6.7

137

851

DPA30

NOMESCO Finland

Sphenotomy

2.6

6.7

138

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

2.6

6.7

138

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.4

6.7

339

2522

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.4

6.7

192

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.7

6.7

115

683

G83.4

ICD-10 Finland

Cauda equina syndrome

3.3

6.7

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

22.5

6.7

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.0

6.7

309

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

1.8

6.7

484

WZC30, ,

SPAT

1.4

6.7

235

1643

E66.0

ICD-10 Finland

Obesity due to excess calories

2.3

6.6

205

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

2.3

6.6

205

-44

ICPC

Preventive immunization/medic

1.4

6.6

352

2638

L95

ICPC

Osteoporosis

1.7

6.6

119

715

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.1

6.6

303

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

3.7

6.6

RD211, ,

NOMESCO Finland

1.5

6.6

194

1308

XA420

NOMESCO Finland

Extensive sleep examination

2.2

6.6

244

R06AX12

ATC

terfenadine; oral

1.5

6.6

213

1464

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

1.9

6.6

386

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.8

6.6

522

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

2.7

6.6

122

XKC03

NOMESCO Finland

Water cystometry

1.7

6.6

118

709

XX9XE

NOMESCO Finland

Other ultrasound examination

2.5

6.6

163

J01

ICD-10 Finland

Acute sinusitis

1.4

6.6

233

1631

K93

ICPC

Pulmonary embolism

2.3

6.6

200

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.8

6.6

545

R4180

NOMESCO Finland

Podiatric therapy

2.1

6.6

271

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

3.4

6.5

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

6.5

400

3061

A10BJ06

ATC

semaglutide; parenteral

1.5

6.5

222

1541

B37.8

ICD-10 Finland

Candidiasis of other sites

4.2

6.5

W84

ICD-10 Finland

Unspecified threat to breathing

3.8

6.5

L60.0

ICD-10 Finland

Ingrowing nail

1.5

6.5

213

1468

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.6

6.5

140

F32

ICD-10 Finland

Depressive episode

1.4

6.5

243

1717

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.8

6.5

466

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.6

6.5

124

757

SPAT1244

SPAT

Occupational therapy

2.3

6.5

201

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.5

6.5

220

1527

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.1

6.5

259

A07EC02

ATC

mesalazine; oral, rectal

1.4

6.5

252

1794

SPF02

NOMESCO Finland

Impression for dental prosthesis repair, restricted

2.2

6.5

246

R1250

NOMESCO Finland

Evaluation of functional capability

1.7

6.5

103

599

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.1

6.5

279

A03DA02

ATC

pitofenone and analgesics; systemic

1.9

6.5

424

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.4

6.5

230

1611

M79.1

ICD-10 Finland

Myalgia

1.2

6.5

674

5518

P25

ICPC

Phase of life problem adult

1.5

6.5

179

1193

J32.4

ICD-10 Finland

Chronic pansinusitis

1.9

6.5

361

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.7

6.5

106

622

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.6

6.4

157

1017

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

6.4

402

3086

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.7

6.4

103

600

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.7

6.4

119

721

A07DA03

ATC

loperamide; oral

1.6

6.4

146

931

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.1

6.4

260

K05.31

ICD-10 Finland

Periodontitis pronounced

1.3

6.4

482

3794

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

1.9

6.4

369

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.5

6.4

176

1171

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

3.4

6.4

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

2.8

6.4

107

J06.80

ICD-10 Finland

Continuously repeating infections of a child

7.4

6.4

K04.0

ICD-10 Finland

Pulpitis

1.3

6.4

473

3716

N04BC05

ATC

pramipexole; oral

1.4

6.4

314

2326

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.9

6.4

426

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

1.7

6.4

113

677

C03AA03

ATC

hydrochlorothiazide; oral

1.3

6.4

380

2898

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

2.8

6.4

113

RK320, ,

NOMESCO Finland

2.4

6.4

178

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

2.4

6.4

178

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

3.7

6.4

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.2

6.3

216

K11.2

ICD-10 Finland

Sialoadenitis

1.6

6.3

141

895

IGV01

NOMESCO Finland

Psychiatric network contact

2.1

6.3

255

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

6.5

6.3

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

8.1

6.3

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

6.3

625

5087

C02DE04, ,

ATC

1.7

6.3

111

664

137

Kela drug reimbursment

Uraemia requiring dialysis

2.2

6.3

210

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

6.3

236

1669

J02.0

ICD-10 Finland

Streptococcal pharyngitis

1.7

6.3

103

604

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

6.3

471

3706

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

5.5

6.3

M01AX01

ATC

nabumetone; oral

1.5

6.3

170

1128

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

3.4

6.3

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.1

6.3

256

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

1.9

6.3

351

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.1

6.3

276

IGY02, ,

SPAT

2.1

6.3

276

R4130

NOMESCO Finland

Speech therapy

1.7

6.2

113

681

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

6.2

273

1984

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.7

6.2

109

651

K81.9

ICD-10 Finland

Cholecystitis, unspecified

2.1

6.2

250

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

26.7

6.2

304

Kela drug reimbursment

Dornase alfa

26.7

6.2

JAH01

NOMESCO Finland

Laparoscopy

1.5

6.2

179

1203

F02

ICPC

Red eye

1.5

6.2

186

1260

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.6

6.2

119

728

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.5

6.2

188

1277

XF640, ,

NOMESCO Finland

1.6

6.2

118

721

I49.5

ICD-10 Finland

Sick sinus syndrome

1.5

6.2

160

1051

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.4

6.2

215

1500

J01XX08

ATC

linezolid; systemic

2.6

6.2

132

S91

ICPC

Psoriasis

2.3

6.2

193

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.5

6.2

154

1004

K29

ICPC

Cardiovascular sympt/complt other

1.5

6.2

183

1238

R03BB02

ATC

oxitropium bromide; inhalant

2.7

6.2

115

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

4.0

6.2

I27.0

ICD-10 Finland

Primary pulmonary hypertension

4.0

6.2

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

4.0

6.2

D72.1

ICD-10 Finland

Eosinophilia

3.1

6.1

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

2.3

6.1

181

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.6

6.1

136

863

K50.9

ICD-10 Finland

Crohn disease, unspecified

1.9

6.1

375

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.3

6.1

415

3223

R01AC01

ATC

cromoglicic acid; nasal

1.5

6.1

163

1078

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

2.0

6.1

299

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

7.7

6.1

M54.2

ICD-10 Finland

Cervicalgia

1.3

6.1

356

2707

ZXH06, ,

SPAT

1.5

6.1

193

1323

A49

ICPC

General and Unspecified, Other preventive procedure

2.5

6.1

145

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

2.5

6.1

151

SCA02

NOMESCO Finland

Preventive oral health care

1.3

6.1

497

3955

F01.9

ICD-10 Finland

Vascular dementia, unspecified

1.9

6.1

348

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

3.8

6.1

N03AX11

ATC

topiramate; oral

1.7

6.1

104

618

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

6.1

580

4702

I26

ICD-10 Finland

Pulmonary embolism

2.3

6.1

182

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

3.0

6.1

K04.08

ICD-10 Finland

Other specified pulpit

1.3

6.1

374

2868

UDQ02

NOMESCO Finland

Direct laryngoscopy

2.3

6.0

176

M54.8

ICD-10 Finland

Other dorsalgia

1.5

6.0

187

1276

N06AX22

ATC

agomelatine; oral

1.7

6.0

106

634

F20.5

ICD-10 Finland

Residual schizophrenia

2.6

6.0

122

79388

ICD-8 Finland

Observation, without need for further medical care, Morbi alii definiti

2.6

6.0

122

30180

ICD-8 Finland

Personality disorders, Immatura

2.8

6.0

105

XF402

NOMESCO Finland

ECG with work load test

1.3

6.0

459

3620

GD1UN

NOMESCO Finland

Lung circulation SPECT

2.9

6.0

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

6.0

208

L30.3

ICD-10 Finland

Infective dermatitis

1.5

6.0

155

1018

N05BA09

ATC

clobazam; oral

2.5

6.0

134

AS2

Ventricular pacemaker insertion VVI (R)

2.5

6.0

134

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

6.0

260

1887

K04.1

ICD-10 Finland

Necrosis of pulp

1.3

6.0

535

4302

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2146

8186

3.33

307.65

2.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1732

5551

3.81

307.65

2.6

1.6

—

(3023368) Bacteria identified in Blood by Culture

3042

14294

2.98

307.65

6.5

4.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1725

5608

3.74

307.65

2.7

1.7

—

(3023419) Bacteria identified in Sputum by Culture

380

619

6.43

223.63

4.3

2.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

512

1141

4.76

213.49

2.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

500

1106

4.79

210.33

2.5

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1364

5953

2.60

194.82

10.0

7.5

5.16

5.08

kpa

2.23

1312

5674

(3027801) Oxygen [Partial pressure] in Arterial blood

1362

5951

2.60

194.01

10.0

7.4

10.72

12.58

kpa

46.29

1310

5678

(3003396) Base excess in Arterial blood by calculation

1353

5956

2.57

189.36

10.0

7.5

1.77

0.97

mmol/l

9.63

1141

4639

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

394

791

5.22

185.43

2.0

1.3

—

(3016502) Oxygen saturation in Arterial blood

1244

5349

2.61

182.19

10.4

7.9

94.52

95.82

7.97

1194

5150

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

570

1588

3.82

176.07

3.8

2.5

—

(3019060) Gas panel - Arterial blood

908

3377

2.94

175.62

7.0

4.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

383

798

5.02

172.55

2.5

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

383

798

5.02

172.55

2.5

1.5

—

(3013115) Eosinophils [#/volume] in Blood

4011

28201

1.97

164.35

9.2

6.1

0.20

e9/l

1.47

3662

24765

(3001604) Monocytes [#/volume] in Blood

3901

27181

1.97

163.99

8.7

5.9

0.64

0.59

e9/l

25.65

3517

23561

(3006315) Basophils [#/volume] in Blood

3902

27247

1.96

162.34

8.7

5.9

0.04

e9/l

0.55

3519

23605

(40760892) CBC W Ordered Manual Differential panel - Blood

3711

25511

1.95

161.33

9.7

6.4

—

(3019198) Lymphocytes [#/volume] in Blood

3977

28054

1.95

159.37

8.8

5.9

1.94

e9/l

0.07

3658

24854

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1131

4964

2.52

156.90

10.9

8.2

122.34

122.57

g/l

0.13

1104

4839

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

337

682

5.14

156.90

1.8

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

310

592

5.43

154.05

1.8

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

413

1020

4.24

150.30

1.7

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

413

1020

4.24

150.30

1.7

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1132

5075

2.46

149.50

5.8

4.0

5.95

5.82

kpa

3.82

1090

4923

(3002032) Base excess in Venous blood by calculation

1128

5055

2.46

149.07

5.9

4.1

2.40

1.85

mmol/l

4.79

988

4230

(3013650) Neutrophils [#/volume] in Blood by Automated count

4262

31222

1.92

147.33

13.9

8.8

4.64

4.14

e9/l

31.40

3873

27204

(3019069) Monocytes/100 leukocytes in Blood

3681

25718

1.90

147.29

9.6

6.4

8.61

8.65

0.34

3530

24128

(3022096) Basophils/100 leukocytes in Blood

3576

24764

1.90

146.95

9.1

6.1

0.60

0.67

12.27

3429

23155

(3006504) Eosinophils/100 leukocytes in Blood

3661

25578

1.89

146.02

9.2

6.1

2.75

2.86

2.12

3506

23951

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

616

2032

3.22

145.77

2.6

1.9

1.41

2.41

ug/l

1.49

570

1799

(3012544) pH of Venous blood

1154

5275

2.42

145.74

5.7

4.0

7.37

7.38

—

(3018010) Neutrophils/100 leukocytes in Blood

3711

26113

1.88

144.00

8.9

5.9

59.33

57.20

21.22

3558

24564

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

291

558

5.40

143.88

2.1

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

291

558

5.40

143.88

2.1

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3846

27417

1.88

142.81

8.5

6.0

10.94

12.04

umol/l

7.23

3693

26026

(3022217) INR in Platelet poor plasma by Coagulation assay

3550

24672

1.88

142.79

18.3

14.7

1.25

1.28

inr

0.94

1072

7186

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

885

3614

2.66

141.64

2.1

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

3740

26521

1.87

140.20

9.3

6.1

25.61

27.93

29.74

3586

24952

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

301

615

5.07

138.46

2.0

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

350

813

4.48

137.78

2.6

1.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3617

25621

1.84

133.62

11.8

6.6

1.21

mmol/l

4.13

3216

21795

(3026008) Bacteria identified in Urine by Culture

2356

14600

1.92

132.73

4.3

3.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3335

23109

1.84

131.70

10.8

6.0

1.20

1.21

mmol/l

10.04

3172

21201

(3008152) Bicarbonate [Moles/volume] in Arterial blood

812

3320

2.63

129.05

10.3

7.0

25.55

24.39

mmol/l

12.64

777

3163

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

769

3073

2.69

127.90

1.9

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4233

31708

1.83

127.86

8.4

4.7

6.89

6.74

mmol/l

4.07

4064

29632

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

206

324

6.52

125.01

2.1

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2266

14213

1.87

120.54

4.5

3.0

1860.59

1485.93

ng/l

2.52

1997

12068

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2553

16687

1.83

118.50

3.5

2.6

55.20

72.45

u/l

1.67

2415

15505

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

288

648

4.59

117.87

2.2

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

945

4328

2.37

117.09

4.7

2.9

231.85

203.58

ng/l

1.18

842

3893

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1757

10246

1.95

115.99

5.6

3.6

368.50

620.05

ng/l

1.24

1376

7863

(3014111) Lactate [Moles/volume] in Serum or Plasma

988

4659

2.30

114.22

9.5

7.2

1.42

1.40

mmol/l

0.24

961

4520

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2932

20137

1.78

114.07

5.3

3.4

49.65

83.57

ng/l

0.71

2120

13328

(3018418) pH of Serum or Plasma

2326

14948

1.83

112.89

5.9

3.9

7.40

0.10

446

2880

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

702

2858

2.62

111.87

12.9

10.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

908

4179

2.35

110.89

5.2

3.5

4.75

4.64

kpa

0.77

872

4041

(3005322) IgE [Units/volume] in Serum or Plasma

760

3241

2.51

109.88

1.7

1.2

429.07

247.52

u/ml

1.74

707

3020

(3042936) Bacteria identified in Isolate by Culture

1390

7616

2.03

108.91

2.6

2.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1928

11798

1.87

108.78

2.4

1.8

1.13

1.20

mg/l

0.40

1572

8931

(3024561) Albumin [Mass/volume] in Serum or Plasma

3206

22826

1.74

108.12

7.4

4.9

34.29

35.70

g/l

33.25

3013

21245

(3000991) Gas panel - Venous blood

946

4512

2.27

105.94

11.1

8.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

568

2143

2.79

104.93

7.8

5.2

0.89

0.90

0.14

535

2013

(3004119) Hemoglobin [Mass/volume] in Venous blood

744

3218

2.47

104.09

5.7

3.4

126.98

130.48

g/l

3.77

729

3144

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

566

2168

2.75

101.48

7.7

5.1

1.84

1.70

1.73

535

2032

(3031040) Bacteria [#/volume] in Urine by Automated count

4408

34619

1.72

101.08

6.4

4.1

1037.79

1470.70

e6/l

0.27

512

(3026782) Osmolality of Urine

1755

10679

1.86

99.37

4.1

2.8

538.99

555.58

mosm/kgh2o

2.26

1577

9175

(3005719) IgG [Mass/volume] in Serum or Plasma

855

4028

2.28

98.20

3.8

2.5

9.88

10.66

g/l

5.73

802

3674

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

237

528

4.61

98.11

2.4

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

619

2544

2.57

96.25

5.9

3.4

25.73

25.17

mmol/l

2.94

600

2459

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1267

7004

1.99

95.52

9.6

6.0

1.08

1.04

mmol/l

3.85

1201

6548

(3020779) Urea [Moles/volume] in Serum or Plasma

978

4935

2.14

94.48

12.0

7.5

10.48

9.68

mmol/l

2.39

936

4720

(3047181) Lactate [Moles/volume] in Blood

472

1711

2.88

93.73

8.9

5.9

1.34

1.32

mmol/l

0.10

436

1504

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2607

18096

1.70

92.10

4.1

3.2

32.09

35.61

u/l

2.02

2505

17161

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

354

1104

3.32

91.06

9.9

5.5

330.18

668.35

iu/ml

0.98

155

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

211

457

4.73

90.40

4.6

3.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1446

8523

1.88

89.28

5.6

3.5

0.81

0.82

mmol/l

1.63

1369

7984

(3037692) Legionella sp identified in Specimen by Organism specific culture

116

140

8.41

88.99

1.8

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5004

41353

1.72

88.54

11.1

7.1

80.16

78.26

u/l

2.05

4845

39097

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1346

7828

1.89

86.32

3.4

2.4

2.29

2.33

g/l

1.51

1265

7265

(3028026) IgM [Mass/volume] in Serum or Plasma

684

3088

2.34

86.31

2.3

1.8

1.31

1.33

g/l

0.08

632

2834

(3002582) Erythrocytes [#/volume] in Urine

2376

16322

1.69

85.80

4.6

3.2

60.35

105.99

e6/l

1.79

1944

12508

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

413

1460

2.94

85.73

1.5

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

228

548

4.27

85.64

2.5

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

214

492

4.45

85.13

2.6

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1275

7318

1.91

85.02

3.5

2.5

20.67

23.50

10.15

1025

6263

(3028192) IgG subclass 2 [Mass/volume] in Serum

217

518

4.29

82.24

1.5

1.3

2.69

3.03

g/l

1.88

161

360

(3027135) IgG subclass 1 [Mass/volume] in Serum

217

519

4.28

82.03

1.5

1.3

6.73

6.75

g/l

0.02

161

361

(3024139) IgG subclass 3 [Mass/volume] in Serum

216

518

4.27

81.36

1.5

1.3

0.38

0.41

g/l

0.82

161

359

(3022948) Iron [Moles/volume] in Serum or Plasma

1410

8477

1.83

80.75

3.5

2.4

11.62

13.42

umol/l

18.43

1324

7936

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

640

2911

2.32

79.12

2.4

1.6

—

(4062490) Immunoglobulin typing, IgG

214

523

4.19

78.62

1.5

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1130

6382

1.92

78.57

2.2

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

2171

14837

1.67

78.39

4.4

3.1

0.44

0.42

e6/l

0.19

1757

11263

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

550

2350

2.45

78.27

6.6

3.8

51.33

49.06

1.26

545

2321

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1073

5971

1.94

77.95

5.9

4.3

245.94

243.28

u/l

0.22

1032

5635

(3000850) Epithelial cells [#/volume] in Urine

1739

11232

1.73

77.39

3.4

2.5

5.47

5.12

e6/l

0.57

1603

10087

(3017181) Myelocytes/100 leukocytes in Blood

856

4420

2.07

76.83

5.4

4.2

0.90

0.94

0.17

367

1472

(3039000) Anion gap in Blood

348

1188

3.03

76.76

10.0

7.0

11.12

11.32

mmol/l

0.48

318

1070

(3018572) Chloride [Moles/volume] in Blood

348

1189

3.03

76.65

10.0

7.0

104.46

105.24

mmol/l

2.04

318

1071

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2285

15928

1.64

75.79

3.0

2.1

197.07

231.01

u/l

1.13

2177

14974

(3009261) Glucose [Presence] in Urine by Test strip

3437

26579

1.57

72.67

4.8

3.4

0.00

estimate

0.07

633

4696

(3018095) Leukocytes [#/volume] in Urine

2604

18910

1.60

72.12

5.5

3.6

94.35

88.70

e6/l

0.11

2048

13467

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

593

2716

2.29

71.90

11.8

9.8

24.62

24.18

mmol/l

2.39

574

2622

(3035350) Ketones [Presence] in Urine by Test strip

3412

26384

1.57

71.86

4.8

3.4

0.00

estimate

2.27

696

5151

(3037467) Urinalysis macro (dipstick) panel - Urine

4492

36996

1.59

71.53

6.0

4.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

3400

26303

1.56

71.24

6.5

4.6

0.00

estimate

0.50

656

4876

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

156

322

4.93

70.78

1.6

1.2

1.05

1.60

u/ml

0.56

105

164

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1347

8308

1.77

69.60

2.9

2.3

30.00

29.93

0.19

1310

8061

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

310

1048

3.05

69.50

2.1

1.5

—

(36304419) Bacteria [Presence] in Urine

2094

14529

1.63

69.48

4.3

3.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

583

2704

2.26

68.50

5.2

4.5

24.56

24.00

mmol/l

4.03

574

2651

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

271

855

3.26

68.28

4.3

3.0

2730.75

1475.62

u/ml

0.21

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

161

353

4.64

67.95

1.3

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

509

2237

2.37

67.80

1.7

1.6

19.37

12.05

u/ml

0.25

(40758558) Short blood count panel - Blood

1975

13586

1.63

67.47

10.1

6.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

170

399

4.34

65.86

2.6

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

170

399

4.34

65.86

2.6

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

170

399

4.34

65.86

2.6

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

686

3449

2.09

65.65

7.2

3.5

5.26

5.13

kpa

2.90

652

3255

(3002179) Metamyelocytes/100 leukocytes in Blood

771

4048

2.02

65.55

5.3

4.0

0.64

0.71

0.50

311

1284

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1361

8549

1.73

65.49

4.0

2.9

2.91

2.09

e6/l

2.33

788

4608

(3009343) pH of Capillary blood

675

3405

2.09

63.96

7.2

3.5

7.42

7.41

0.37

369

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1936

13395

1.61

63.95

2.7

2.2

3.09

2.91

mg/l

2.55

1704

11522

(3015235) Bicarbonate [Moles/volume] in Capillary blood

346

1301

2.74

63.79

5.6

3.0

25.19

24.55

mmol/l

1.73

330

1275

(3000494) Fungus identified in Specimen by Culture

1054

6206

1.82

63.12

2.1

1.4

—

(3021589) Normoblasts [#/volume] in Blood

3115

24086

1.52

62.42

13.9

9.3

0.00

e9/l

0.27

2608

19682

(3024891) Influenza virus A+B Ag [Presence] in Specimen

370

1456

2.63

62.34

1.4

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

651

3294

2.08

61.08

7.2

3.5

2.31

1.62

mmol/l

4.59

497

2362

(3013707) Erythrocyte sedimentation rate by Westergren method

4708

39895

1.54

59.99

5.6

3.8

14.91

11.18

mm/h

40.59

4510

37065

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

650

3329

2.05

58.94

12.8

9.4

0.64

0.67

1.13

641

3306

(3024980) IgG subclass 4 [Mass/volume] in Serum

258

869

3.04

58.17

1.6

0.65

0.80

g/l

1.37

194

667

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

648

3332

2.04

58.09

12.8

9.3

1.49

1.37

1.82

639

3310

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6176

56028

1.80

58.04

28.9

13.2

26.81

24.21

mg/l

8.55

5538

44109

(3021440) Promyelocytes/100 leukocytes in Blood

769

4204

1.93

57.81

5.6

4.2

0.12

0.10

0.24

283

1256

(3011412) CD3 cells [#/volume] in Blood

188

523

3.67

57.60

2.5

2.6

1.32

1.19

e9/l

1.13

161

461

(3019150) Specific gravity of Urine by Refractometry

1690

11577

1.60

57.08

5.0

3.7

1.02

kg/l

0.03

227

1695

(3015736) pH of Urine

2801

21466

1.50

56.86

4.4

3.1

5.88

5.82

0.35

163

1874

(3036481) Cortisol [Moles/volume] in Serum or Plasma

862

4937

1.85

56.01

2.5

2.2

347.70

368.06

nmol/l

2.11

812

4536

(3028626) Oxygen [Partial pressure] in Capillary blood

335

1329

2.60

55.46

6.7

3.6

8.34

8.45

kpa

0.49

325

1292

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1389

9130

1.65

55.24

3.6

2.7

1.46

1.11

e6/l

0.67

816

5158

(3025159) Blasts/100 leukocytes in Blood

729

4007

1.91

53.73

5.7

4.2

0.36

0.34

0.02

246

1074

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

149

372

4.07

53.22

2.5

2.8

0.25

0.22

e9/l

0.63

124

316

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

151

388

3.95

51.85

2.5

2.7

649.60

523.29

e6/l

1.53

124

320

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

402

1802

2.30

50.91

5.1

3.8

0.33

0.34

u/ml

0.08

259

1010

(3020630) Protein [Mass/volume] in Serum or Plasma

741

4168

1.87

50.73

3.5

2.3

65.24

66.49

g/l

4.08

691

3814

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2674

20651

1.47

50.45

5.1

3.5

—

(3042631) Mycobacterium sp identified in Specimen

197

621

3.23

49.70

3.8

2.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4434

37827

1.46

48.81

3.7

3.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

149

397

3.81

48.64

1.9

2.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2969

23517

1.45

48.51

3.6

2.8

154.15

131.87

ug/l

3.38

2792

21917

(3021901) Oxygen saturation in Capillary blood

249

913

2.79

48.11

4.4

2.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1983

14528

1.51

48.08

3.8

2.5

3711.60

4127.40

umol/l

0.18

1781

12871

(3027945) Reticulocytes/100 erythrocytes in Blood

955

5897

1.72

47.49

3.3

2.7

1.90

1.75

3.27

866

5214

(3002385) Erythrocyte distribution width [Ratio]

5417

48272

1.52

46.40

30.4

15.8

14.68

14.77

0.35

5369

47384

(4200892) Spirometry reversibility

638

3531

1.89

45.75

1.7

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

401

1880

2.20

45.52

6.1

4.0

1.32

1.39

mmol/l

1.00

387

1850

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

973

6105

1.69

45.46

3.5

2.9

9.84

8.93

umol/l

0.48

836

5326

(3033658) Prothrombin time (PT) actual/Normal

1898

13914

1.50

45.37

5.7

4.1

88.60

89.01

0.29

1849

13576

(3015377) Calcium [Moles/volume] in Serum or Plasma

2250

17067

1.47

45.28

4.5

3.3

2.34

2.35

mmol/l

5.30

2034

15140

(1175426) CD3 cells/100 lymphocytes in Blood

150

423

3.60

45.08

1.9

2.4

73.43

71.80

0.58

142

404

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

147

413

3.61

44.43

1.9

2.4

13.67

15.03

0.81

141

402

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

133

350

3.85

44.21

2.2

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1500

10525

1.54

43.90

2.1

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2659

20918

1.43

43.64

2.1

1.9

91.92

95.20

pmol/l

3.42

1569

11275

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

272

4.24

43.30

2.2

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

646

3656

1.84

43.08

5.6

4.0

108.04

90.79

ng/l

3.06

577

3197

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

338

1513

2.30

42.88

1.7

1.6

0.23

g/l

0.03

319

1437

(3019309) Folate [Moles/volume] in Red Blood Cells

1374

9526

1.55

42.26

1.8

1.7

1197.25

1164.46

nmol/l

0.59

1103

7248

(3037522) Nuclear Ab [Titer] in Serum

1088

7149

1.62

42.15

1.5

1.3

437.88

503.58

titre

0.71

226

1367

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

183

4.97

41.64

1.7

1.6

1632.09

27592.39

u/ml

0.52

(3011397) Hemoglobin [Presence] in Urine by Test strip

1671

12130

1.49

41.24

4.6

3.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6130

56572

1.62

40.76

30.4

15.1

139.33

139.61

mmol/l

14.64

6063

55128

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

218

815

2.73

40.60

1.8

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

200

715

2.85

40.54

7.5

6.9

11.08

11.51

mg/l

0.68

185

668

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

100

228

4.43

40.29

1.6

2.5

31.50

28.85

0.84

217

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

174

578

3.06

40.22

1.2

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

340

1568

2.23

40.15

1.8

1.6

1.21

1.18

g/l

1.19

321

1487

(3023103) Potassium [Moles/volume] in Serum or Plasma

6143

56784

1.62

39.82

30.5

15.2

3.98

mmol/l

0.42

6061

55224

(3020891) Body temperature

420

2109

2.05

39.82

8.2

4.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

101

235

4.35

39.66

1.8

2.6

11.14

11.26

0.03

219

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2665

21233

1.41

39.60

2.7

2.2

75.69

75.33

nmol/l

0.26

2469

19245

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

803

4966

1.70

39.25

2.7

2.3

0.21

g/l

0.69

745

4619

(3023520) Reticulocytes [#/volume] in Blood

721

4330

1.74

39.20

3.4

2.6

72.57

69.13

e9/l

1.59

569

3250

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

101

238

4.29

39.02

2.3

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1862

13950

1.45

38.70

5.3

3.8

0.00

estimate

2.60

633

4639

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3076

25186

1.39

38.60

3.4

2.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1460

10436

1.50

38.47

1.7

1.4

2.43

g/l

0.03

1036

6554

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

455

2390

1.97

37.99

2.0

1.7

1.61

1.50

g/l

1.63

405

2039

(1616796) Gas panel - Central venous blood

270

1157

2.39

37.86

5.5

3.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

238

4.20

37.27

2.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

6.60

36.91

2.0

2.3

—

(40757373) Influenza virus identified in Isolate

6.33

36.68

2.0

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

261

1128

2.36

35.90

3.1

2.1

128.83

130.23

g/l

0.33

196

815

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

794

5025

1.65

35.34

3.2

2.6

75.79

52.63

u/l

0.22

670

4351

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

736

4572

1.68

35.18

3.0

2.3

8.22

7.83

ug/l

0.11

649

4004

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

11.67

35.14

1.4

1.0

—

(3044640) Blood type and Crossmatch panel - Blood

2155

16809

1.41

35.13

3.2

2.4

—

(3044889) 12 lead EKG panel

4348

37979

1.37

35.11

4.4

3.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

241

4.07

34.97

3.4

1.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

583

3400

1.78

34.97

3.2

2.1

—

(3028433) Virus identified in Specimen by Culture

177

4.62

34.44

1.3

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

331

1609

2.11

34.19

6.8

4.2

3.92

3.90

mmol/l

0.27

323

1593

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

241

4.02

34.14

3.4

1.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

358

1798

2.04

33.88

1.9

1.6

576.25

316.69

titre

0.48

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

181

4.52

33.52

3.6

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

180

4.48

32.82

3.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

180

4.48

32.82

3.6

2.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1578

11765

1.44

32.75

1.7

1.5

18.71

19.96

nmol/l

2.99

1435

10224

(3017143) Hepatitis C virus Ab [Presence] in Serum

986

6685

1.55

32.72

1.9

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

307

1477

2.13

32.57

4.3

3.0

56.76

93.18

mg/l

0.46

253

1203

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

307

1477

2.13

32.57

4.3

3.0

35.07

49.94

mg/l

1.73

255

1210

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

247

1099

2.29

31.78

1.9

1.5

106.41

112.34

u/ml

0.38

210

(3041096) Erythrocytes [Presence] in Urine by Automated

1899

14702

1.40

31.65

4.4

3.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4601

40855

1.36

31.57

4.2

3.7

14.82

14.71

pmol/l

2.15

4310

37374

(3018851) Theophylline [Moles/volume] in Serum or Plasma

10.67

31.30

1.6

1.4

53.56

41.59

umol/l

0.96

(40761511) CBC panel - Blood by Automated count

6238

58481

1.56

31.17

23.7

12.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

298

1442

2.11

31.15

4.3

2.9

2.71

2.91

ratio

0.06

119

(3026250) Tacrolimus [Mass/volume] in Blood

267

3.71

31.09

39.1

36.2

7.97

7.31

ug/l

2.80

251

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

295

1426

2.12

30.92

1.4

24.27

12.17

iu/ml

—

(3022313) Gas panel - Capillary blood

451

2526

1.84

30.85

7.5

3.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

318

1583

2.06

30.82

2.0

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

260

1199

2.21

30.70

1.9

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

248

1124

2.25

30.55

4.6

2.9

—

(40767503) Oxygen content in Capillary blood by calculation

241

1080

2.27

30.50

3.9

2.4

16.28

16.50

0.32

132

519

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

259

1198

2.21

30.36

1.8

1.4

35.31

16.99

u/ml

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

10.04

30.02

1.7

1.5

1.92

1.46

mg/l

0.18

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

10.04

30.02

1.7

1.5

1.62

2.49

mg/l

0.29

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

10.04

30.02

1.7

1.5

1.84

0.74

mg/l

0.91

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

10.04

30.02

1.7

1.5

2.58

1.29

mg/l

0.71

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

10.04

30.02

1.7

1.5

4.15

3.94

mg/l

0.04

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

10.04

30.02

1.7

1.5

5.30

4.19

mg/l

0.22

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

10.04

30.02

1.7

1.5

1.34

2.11

mg/l

0.42

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

10.04

30.02

1.7

1.5

2.39

1.10

mg/l

0.40

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

10.04

30.02

1.7

1.5

2.84

2.81

mg/l

0.01

(3010421) pH of Blood

289

1406

2.10

29.79

6.5

3.9

7.42

0.36

251

1272

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

323

1645

2.01

29.40

4.0

3.3

3.75

3.52

g/l

1.61

311

1556

(3009508) Creatinine [Moles/volume] in Urine

2102

16726

1.37

29.12

3.5

3.3

7.68

8.10

mmol/l

3.73

1854

14301

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

9.49

28.82

1.7

1.5

1.71

1.24

mg/l

0.24

(3037756) Immunofixation for Serum or Plasma

226

1017

2.26

28.34

2.0

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

353

1878

1.93

28.31

3.0

2.4

625.78

578.13

ug/l

0.09

331

1774

(3000060) B lymphocytes [#/volume] in Blood

169

4.29

28.04

1.7

2.6

290.54

235.44

e6/l

0.32

(3027456) Digoxin [Moles/volume] in Serum or Plasma

209

916

2.32

27.89

3.2

3.0

0.83

nmol/l

0.09

169

686

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

120

4.95

27.38

1.4

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

356

1923

1.90

27.27

1.3

1.2

1.31

0.70

u/ml

0.38

170

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.78

26.87

1.4

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

252

1216

2.11

26.55

3.2

2.9

32.37

35.50

umol/l

1.13

236

1101

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

257

1250

2.10

26.52

1.5

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

348

1892

1.88

26.13

1.5

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

245

1177

2.12

26.12

1.5

1.3

251.83

265.27

u/ml

0.34

161

740

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

283

1440

2.01

25.83

2.2

2.0

11.43

10.95

mg/l

0.43

271

1346

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

227

3.64

25.48

5.1

3.6

—

(3024928) Oxygen saturation in Venous blood

236

1132

2.12

25.27

4.4

3.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1988

15972

1.34

25.05

4.1

3.9

14.31

9.42

mg/mmol

3.39

1435

10564

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.82

24.58

3.2

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

258

3.40

24.37

36.9

23.5

130.76

119.50

ug/l

0.73

207

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4329

38749

1.30

24.30

3.9

3.1

55.23

49.14

u/l

3.57

4144

36511

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5388

49760

1.35

23.91

5.0

4.4

2.35

2.19

mu/l

0.13

5106

45862

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

106

359

2.98

23.84

2.5

2.7

38.81

41.29

0.68

189

(3012501) Base excess in Blood by calculation

243

1207

2.05

23.73

6.4

4.0

2.78

2.45

mmol/l

0.82

173

788

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1364

10426

1.38

23.45

1.6

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1439

11095

1.37

23.45

1.7

74253861.15

28150783.66

pmol/l

1.13

1239

9364

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

389

2267

1.76

23.25

2.0

1.9

37.32

39.08

u/l

1.01

353

2020

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

130

500

2.63

23.04

2.9

2.7

—

(3052851) Hemolysis interference index of Serum or Plasma

296

1591

1.90

23.03

3.6

3.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6283

59625

1.48

22.97

14.5

9.6

27.65

27.98

u/l

0.57

6161

57680

(3030981) Hyaline casts [#/volume] in Urine by Automated count

463

2848

1.67

22.72

3.9

2.7

0.22

0.27

e6/l

0.78

452

2773

(3023199) Leukocytes [#/volume] in Pleural fluid

149

617

2.45

22.65

1.4

1.5

6779.66

2290.69

e6/l

0.67

108

444

(3025941) Bacteria identified in Stool by Culture

489

3064

1.64

22.32

1.4

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1880

15194

1.32

22.21

3.7

3.3

854.26

370.27

mg/l

2.81

1359

10105

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

5.94

22.10

1.2

36.63

39.07

mg/l

0.12

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

209

1013

2.10

21.82

1.5

1.2

552.00

133.00

titre

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

1905

1.80

21.77

3.2

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

1907

1.79

21.70

3.2

2.1

7.47

7.34

g/l

0.71

313

1726

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

102

357

2.88

21.66

1.7

1.5

13.06

12.84

u/l

0.11

341

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

334

1905

1.79

21.49

3.2

2.1

3.64

3.70

g/l

0.24

312

1725

(3003434) Protein [Mass/volume] in Pleural fluid

157

684

2.32

21.32

1.4

1.5

31.60

32.54

g/l

0.40

142

614

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

312

3.01

21.31

1.7

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

234

1193

1.99

21.28

1.5

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

182

845

2.18

21.22

6.3

5.2

384.86

368.01

umol/l

0.96

169

730

(40761535) Cells panel - Urine sediment

631

4246

1.53

21.21

4.7

3.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

309

1729

1.82

21.19

1.5

1.6

1.16

0.68

iu/ml

0.26

356

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

6.98

21.18

4.0

3.8

1.00

1.50

mg/l

0.42

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

317

1791

1.81

21.06

4.3

3.1

91.00

91.36

0.10

308

1732

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

218

1093

2.03

20.79

1.6

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

124

493

2.54

20.58

1.3

1.4

6.17

6.40

mmol/l

0.36

114

453

(3003181) Sodium [Moles/volume] in Urine

182

856

2.16

20.56

1.4

58.95

64.46

mmol/l

1.09

153

681

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

319

2.94

20.50

1.7

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

178

832

2.17

20.43

4.3

3.5

1.46

1.59

0.21

151

741

(3036489) Thrombin time

354

2087

1.73

20.32

3.3

2.5

22.67

21.47

1.30

315

1828

(3045788) Cell count panel - Pleural fluid

121

481

2.54

20.10

1.4

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

289

1613

1.83

19.99

3.4

2.9

198.61

183.81

2.22

279

1533

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1114

8447

1.38

19.77

1.9

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

232

3.26

19.72

1.5

1.1

—

(3024471) HLA-A [Type]

213

3.36

19.61

1.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

6535

62800

1.52

19.45

37.0

19.4

40.50

40.89

0.23

6107

59069

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

120

483

2.51

19.44

1.3

577.51

358.22

u/l

0.96

111

458

(3007461) Platelets [#/volume] in Blood

6539

62854

1.52

19.36

36.6

19.3

251.44

248.40

e9/l

3.00

6460

61313

(3042733) HLA Ab [Presence] in Serum

205

3.39

19.35

5.2

4.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

281

1571

1.82

19.34

1.9

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

121

491

2.49

19.27

2.5

2.6

36.84

37.73

0.24

116

486

(3024731) MCV [Entitic volume]

6542

62903

1.52

19.18

36.4

19.2

90.91

90.71

2.90

6501

62045

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

368

2228

1.69

19.17

8.5

3.8

25.04

24.69

mmol/l

1.50

358

2058

(3035941) MCH [Entitic mass]

6541

62895

1.52

19.13

36.3

19.2

30.23

30.31

2.76

6499

62039

(3026361) Erythrocytes [#/volume] in Blood

6542

62911

1.52

19.08

36.5

19.3

4.48

4.56

e12/l

28.21

6444

61189

(3052592) Norovirus Ag [Presence] in Stool

4.70

18.87

1.9

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

307

1776

1.76

18.84

3.2

2.2

9.73

10.29

g/l

1.25

280

1587

(3010813) Leukocytes [#/volume] in Blood

6541

62919

1.52

18.83

36.6

19.3

7.30

6.75

e9/l

42.19

6451

61174

(3001964) Herpes simplex virus Ag [Presence] in Specimen

134

3.98

18.81

2.3

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

144

639

2.28

18.79

4.0

2.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

363

2.72

18.78

1.2

1.3

13.54

14.16

u/l

0.13

332

(3000963) Hemoglobin [Mass/volume] in Blood

6542

62936

1.52

18.76

36.8

19.4

134.44

137.46

g/l

43.28

6499

62080

(3000492) Spirometry study

799

5776

1.43

18.65

1.8

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

215

1117

1.95

18.57

1.9

1.6

—

(3003338) MCHC [Mass/volume]

5290

49274

1.29

18.45

32.4

16.7

331.95

333.48

g/l

26.78

5262

48846

(3024932) HLA-DR beta [Type]

212

3.28

18.37

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

127

541

2.37

18.21

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1131

8708

1.36

18.08

1.3

54.16

29.79

iu/ml

0.52

363

2769

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

227

1217

1.89

17.86

1.5

1.6

3327.88

1328.60

e6/l

0.34

190

1002

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

227

1217

1.89

17.86

1.4

1.6

26.68

22.81

e6/l

0.09

183

949

(3028308) Erythrocytes [#/volume] in Pleural fluid

128

553

2.34

17.79

1.4

1.5

61739.99

61247.19

e6/l

0.01

328

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1179

9159

1.34

17.74

3.3

3.0

2.46

2.44

mmol/l

2.97

1041

7973

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

137

611

2.27

17.69

1.4

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

117

488

2.42

17.60

1.5

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

273

1562

1.78

17.42

1.4

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

303

1790

1.72

17.29

3.2

2.2

3.02

2.95

g/l

0.61

282

1610

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

597

4141

1.48

17.27

5.1

3.6

1.22

mmol/l

2.90

561

3624

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

347

2128

1.66

17.22

3.4

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

622

4360

1.47

17.05

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

278

1611

1.76

16.98

3.0

2.3

0.92

0.96

g/l

0.05

247

1395

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1571

12808

1.29

16.57

3.1

2.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

140

648

2.18

16.54

2.7

2.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

165

818

2.04

16.31

2.0

1.6

—

(3017569) Oxygen content in Arterial blood

244

2.97

16.30

2.2

—

(3035880) pH of Pleural fluid

288

2.80

16.24

1.2

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

193

1014

1.93

16.17

1.8

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

274

1622

1.72

15.54

4.6

1.65

1.43

mg/l

3.45

259

1504

(1761482) Bacteria [#/volume] in Urine by Culture

232

1310

1.80

15.51

6.1

3.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

377

2.51

15.43

1.4

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

142

685

2.09

15.13

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

717

5269

1.40

15.13

4.6

3.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

458

3091

1.51

15.12

3.3

4.47

4.51

pmol/l

0.33

411

2737

(21494890) Protein electrophoresis panel - 24 hour Urine

111

486

2.30

15.03

2.6

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1050

8201

1.33

15.02

1.3

1.2

10.91

11.31

u/ml

0.07

395

3290

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

246

1429

1.75

14.94

2.7

2.2

0.01

0.03

g/l

0.66

226

1311

(3047007) Chlamydophila sp Ab [Presence] in Serum

159

805

2.00

14.86

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

308

1926

1.63

14.20

2.8

1.8

—

(3012441) Differential panel - Pleural fluid

115

526

2.21

14.06

1.4

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

200

1124

1.80

13.63

2.2

3.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5491

51941

1.25

13.61

21.7

12.3

83.11

83.65

ml/min/173m2

0.91

4680

42959

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

213

1222

1.77

13.54

1.3

1.4

4.03

3.75

mmol/l

1.95

203

1148

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

250

1501

1.69

13.51

1.2

1.1

—

(3019977) pH of Arterial blood

294

2.60

13.49

2.5

2.6

7.42

0.09

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.99

13.32

1.5

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

180

3.07

13.30

1.5

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

233

1379

1.71

13.28

1.4

1.5

596.53

517.57

mg/l

0.31

224

1318

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

141

713

2.00

13.27

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

162

861

1.90

13.19

1.5

1.2

4.94

3.79

u/ml

0.30

289

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.11

13.13

1.1

—

(4034850) Laboratory test

278

1729

1.63

13.12

14.2

9.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

157

3.20

12.96

4.2

3.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

153

805

1.92

12.85

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

857

6643

1.33

12.80

2.7

2.5

175.05

132.49

ug/g

1.69

707

5349

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

239

2.74

12.76

2.1

3.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

596

4367

1.40

12.75

3.6

2.5

64.54

67.95

ml/min/173m2

0.61

260

1702

(3044242) Glucose [Moles/volume] in Arterial blood

276

2.59

12.51

2.0

2.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

142

741

1.94

12.25

1.1

1.57

1.52

g/l

1.08

128

670

(3036180) Methadone [Presence] in Urine

309

2.48

12.21

1.9

2.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

4.75

12.10

1.2

1.4

59.30

75.14

1.18

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

996

7972

1.29

11.71

2.0

1.8

1.55

1.46

2.65

884

7106

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

205

2.79

11.70

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

155

848

1.85

11.59

1.5

1.2

4.79

4.45

u/ml

0.12

392

(3017704) Immunofixation for Urine

258

2.57

11.53

1.9

1.5

—

(40768446) Kidney Pathology biopsy report

247

2.61

11.48

1.6

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

162

906

1.81

11.29

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

215

1304

1.67

11.24

2.7

2.2

0.00

g/l

-0.00

197

1208

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

217

1323

1.66

11.13

2.7

2.2

0.00

g/l

-0.00

198

1210

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

206

2.73

11.04

3.6

2.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

218

2.67

10.97

2.7

2.8

—

(3011288) Drugs identified in Urine by Screen method

271

1752

1.57

10.94

3.4

3.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

213

2.69

10.91

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

236

1479

1.62

10.86

2.6

2.1

36.32

37.75

g/l

2.61

211

1296

(3000330) Specific gravity of Urine by Test strip

372

2580

1.47

10.78

5.4

3.2

—

(3020393) Adenovirus Ag [Presence] in Stool

4.13

10.59

1.5

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.13

10.59

11.5

9.5

5.45

6.16

mmol/l

0.64

(3000570) Elastase.pancreatic [Mass/mass] in Stool

234

1474

1.61

10.55

1.4

277.78

270.72

ug/g

0.21

135

841

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1400

11794

1.23

10.52

1.3

1.18

1.76

u/ml

2.05

373

3196

(3041918) Cholesterol [Moles/volume] in Pleural fluid

101

3.48

10.41

1.2

1.62

1.73

mmol/l

0.18

(3044290) Cell count panel - Cerebral spinal fluid

186

1110

1.69

10.37

1.4

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

164

945

1.75

10.37

1.2

—

(40768806) Pleura Pathology biopsy report

106

532

2.01

10.29

1.5

1.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.93

10.28

1.1

1.3

100.06

514.39

u/l

0.50

(3020191) Ethanol [Moles/volume] in Serum or Plasma

109

553

1.99

10.27

1.5

1.4

1.29

1.44

promille

0.42

427

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

127

3.16

10.25

1.2

1.3

32.14

23.79

0.65

106

(3000034) Microalbumin [Mass/volume] in Urine

488

2.04

10.11

2.8

3.1

45.75

58.89

mg/l

0.29

364

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

147

827

1.79

10.10

1.2

1.1

116.13

115.08

0.15

138

756

(3023511) Choriogonadotropin [Units/volume] in Urine

170

999

1.72

10.04

1.5

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

430

2.11

9.99

1.2

95.00

152.00

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

430

2.11

9.99

1.2

59.38

195.98

titre

2.99

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

172

2.80

9.98

2.9

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

172

2.80

9.98

2.9

2.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.49

9.87

1.2

1.3

119.83

59.88

ng/l

0.74

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

304

2063

1.49

9.84

2.6

2.3

4789.83

4515.38

u/l

0.06

106

739

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

152

876

1.75

9.64

1.2

44.96

37.39

u/l

0.32

136

761

(3008757) Leukocyte morphology finding [Identifier] in Blood

107

554

1.95

9.54

5.5

4.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

253

2.42

9.49

1.2

1.1

5.33

3.90

iu/ml

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

293

2.30

9.26

1.4

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

151

884

1.72

9.08

1.1

7.33

11.63

au/ml

0.58

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

488

1.98

9.05

1.4

1.3

1.49

1.46

nmol/l

0.10

435

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5264

50186

1.19

9.03

6.3

5.4

41.03

39.64

mmol/mol

17.64

4991

46837

(3023383) Lactate [Moles/volume] in Pleural fluid

165

2.74

8.99

1.2

1.4

2.98

3.57

mmol/l

0.76

151

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

219

1417

1.56

8.88

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

198

1252

1.60

8.86

1.7

1.6

16672.44

14995.41

e6/l

0.17

142

897

(3017354) Segmented neutrophils/100 leukocytes in Blood

100

520

1.94

8.84

5.2

3.6

58.78

56.77

0.43

442

(3050794) Legionella sp Ab [Presence] in Serum

4.88

8.82

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

111

600

1.86

8.73

33.3

5.5

7.28

7.47

mmol/l

0.23

497

(3035637) Corticotropin [Mass/volume] in Plasma

125

702

1.79

8.70

1.7

1.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.55

8.65

1.1

1.3

0.37

1.34

mmol/l

1.33

(40768797) Stomach Pathology biopsy report

857

6981

1.26

8.61

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

504

1.94

8.61

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

194

2.54

8.45

2.5

2.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

257

2.31

8.28

1.3

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

257

2.31

8.28

1.3

1.8

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

257

2.31

8.28

1.8

1.6

1590883.86

1682208.30

iu/ml

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

113

629

1.81

8.13

1.2

1.1

93.91

96.44

0.41

108

594

(3013512) EKG study

1665

14594

1.18

7.96

5.1

3.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

250

2.29

7.89

1.7

2.0

212.00

131.77

umol/l

0.51

137

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

165

1029

1.62

7.86

1.3

1.2

5.61

3.02

u/ml

0.23

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

245

2.30

7.80

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

8.44

7.79

4.0

2.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

196

2.46

7.79

1.4

1.5

58.15

62.34

0.33

158

(3020876) Protein [Mass/time] in 24 hour Urine

103

565

1.84

7.79

2.7

2.4

0.79

1.57

g/24h

3.79

298

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.30

7.77

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

117

2.92

7.68

5.6

6.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

185

1193

1.57

7.67

1.8

5.60

4.44

iu/l

0.47

434

(1001926) Buprenorphine [Presence] in Urine by Screen method

293

2078

1.43

7.63

2.1

2.3

—

(3045142) Bone marrow Pathology biopsy report

535

1.84

7.54

1.5

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

224

1513

1.50

7.51

1.3

63.21

96.15

titre

1.65

135

(3022621) pH of Urine by Test strip

448

3414

1.33

7.51

3.9

2.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

149

919

1.63

7.44

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

135

812

1.68

7.43

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.07

7.41

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

163

1029

1.60

7.41

1.1

2.15

2.02

u/ml

0.06

102

518

(3017315) Amylase [Enzymatic activity/volume] in Urine

296

2.14

7.41

1.3

1.2

179.28

457.87

u/l

2.68

277

(44813793) Dust mix specific IgE antibody measurement

356

2.03

7.41

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

109

619

1.77

7.37

1.4

1.3

40.54

42.95

u/ml

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

106

598

1.78

7.34

2.8

2.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

354

2615

1.37

7.28

2.5

2.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

141

865

1.64

7.21

1.2

1.1

—

(21494434) Karyotype in Bone marrow

429

1.92

7.20

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

180

2.45

7.14

1.4

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

185

1214

1.54

7.13

1.2

1.1

1.62

2.45

u/ml

0.78

114

606

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5490

52834

1.17

7.12

4.6

4.2

6.09

5.94

mmol/l

10.27

5171

48582

(3024666) Lithium [Moles/volume] in Serum or Plasma

362

2.00

7.09

12.9

11.8

0.64

0.62

mmol/l

0.36

326

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

117

2.83

7.09

2.2

2.3

14.01

16.32

umol/l

0.67

117

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

224

2.29

7.08

2.1

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

224

2.29

7.08

2.1

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

218

1486

1.48

7.01

1.3

1.2

344.00

1027.44

titre

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

270

2.16

7.00

1.4

1.3

47.71

65.52

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

621

4995

1.27

6.93

4.0

4.1

14.44

28.68

ug/l

0.98

521

4073

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

105

602

1.76

6.90

1.6

60.47

59.91

0.05

378

(3044941) Cell count panel - Synovial fluid

137

847

1.63

6.82

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

180

1187

1.53

6.80

1.3

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

6.68

6.80

1.1

2.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

109

2.85

6.77

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

109

2.85

6.77

1.4

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

173

2.44

6.74

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

476

1.84

6.69

1.2

59.08

64.86

u/l

0.29

422

(3000012) Reticulocyte production index

120

725

1.67

6.55

3.3

2.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

188

1262

1.50

6.55

1.4

1.2

10.24

6.08

u/ml

0.33

126

(40757494) Bilirubin.total [Moles/volume] in Blood

293

2.06

6.44

2.5

16.33

45.46

umol/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

143

907

1.59

6.43

4.2

3.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

280

2.08

6.42

1.2

110.62

88.51

u/l

0.90

233

(3047189) Immunofixation for 24 hour Urine

222

2.22

6.36

2.2

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

649

5306

1.25

6.30

1.8

1.7

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

109

2.76

6.20

1.4

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

237

1683

1.42

6.20

1.3

166.73

212.63

miu/ml

1.08

752

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

271

2.07

6.17

1.3

1.2

43.06

21.56

u/l

0.82

222

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

156

2.44

6.17

2.4

2.2

—

(3008295) Osmolality of Serum or Plasma

534

1.75

6.13

1.2

1.5

277.41

281.73

mosm/kgh2o

1.08

411

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

383

1.89

6.08

1.3

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

254

1833

1.40

6.07

1.4

1.3

—

(3037121) Protein [Mass/volume] in Urine

262

1904

1.39

6.01

4.2

3.3

0.32

0.34

g/l

0.16

144

872

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

322

1.97

5.99

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

378

1.89

5.99

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

378

1.89

5.99

1.3

1.1

—

(3023410) Appearance of Cerebral spinal fluid

561

1.72

5.96

1.6

2.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

539

1.74

5.95

1.3

1.2

—

32.86

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

135

2.53

5.93

2.5

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

216

2.18

5.92

6.9

6.3

25.77

24.70

mmol/l

1.24

203

(3014765) Yersinia sp identified in Stool by Organism specific culture

219

1549

1.43

5.87

1.3

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

187

1286

1.47

5.83

1.4

1.3

11.87

8.45

u/ml

0.27

212

(3034426) Prothrombin time (PT)

211

2.19

5.82

1.5

1.2

—

(3045414) Leukocytes [Presence] in Urine

305

2285

1.35

5.80

2.3

1.8

—

(3051651) Icteric interference index of Serum or Plasma

319

1.95

5.80

4.2

3.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

383

1.86

5.77

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

383

1.86

5.77

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

219

1556

1.42

5.74

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

252

2.07

5.73

12.8

6.7

77.02

1856.67

mg/l

0.82

182

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

297

3928

0.75

5.72

1.4

—

(3016879) Cocaine [Presence] in Urine

331

2516

1.33

5.71

2.2

—

(36660697) Celiac disease serology panel - Serum

522

4211

1.26

5.71

1.2

—

(1761868) Lipid panel - Serum or Plasma

1933

21254

0.88

5.70

2.8

2.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

212

1500

1.43

5.69

1.1

5.44

6.59

u/ml

0.17

213

(40759836) Histone Ab [Presence] in Serum by Immunoblot

378

1.86

5.67

1.3

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

315

1.94

5.65

1.1

10.20

9.04

iu/ml

0.15

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

188

2.24

5.65

1.3

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

198

1386

1.44

5.64

1.4

1.2

48.45

36.77

u/ml

0.15

(3000764) Benzodiazepines [Presence] in Urine

349

2680

1.32

5.62

2.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

216

1538

1.42

5.60

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

118

742

1.60

5.56

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

477

5908

0.79

5.54

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

304

1.95

5.51

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

311

1.94

5.51

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

281

2100

1.35

5.45

1.1

6.89

1.14

u/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

285

1.97

5.43

1.2

—

(3028300) Cannabinoids [Presence] in Urine

350

2705

1.31

5.39

2.1

—

(40768800) Prostate Pathology biopsy report

1275

0.58

5.37

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

386

1.82

5.34

1.3

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.71

5.25

1.6

1.2

112.32

118.08

mg/l

0.02

(3022145) Colonoscopy Study observation

694

5826

1.21

5.24

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

244

1797

1.37

5.21

1.7

—

(3014891) Appearance of Pleural fluid

3.05

5.21

1.2

—

(3027008) Opiates [Presence] in Urine

346

2698

1.30

5.01

2.1

2.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

297

2269

1.32

5.00

2.4

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

504

6120

0.81

4.90

4.1

4.2

30.57

31.70

1.60

360

4313

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

617

1.61

4.89

1.9

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

136

2.36

4.89

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

472

1.70

4.88

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.34

4.87

1.1

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

155

2.26

4.87

1.3

1.5

1.81

2.75

0.55

128

(3023430) Cat dander IgE Ab [Units/volume] in Serum

121

792

1.54

4.85

1.1

1.0

5.51

5.17

u/ml

0.08

312

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

151

1036

1.47

4.83

1.4

1.2

49.49

35.14

u/ml

0.46

(3003888) Timothy IgE Ab [Units/volume] in Serum

160

1111

1.45

4.81

1.1

4.81

6.44

u/ml

0.77

101

594

(3045424) Erythrocytes [Presence] in Urine

127

844

1.51

4.76

1.7

1.5

—

(3027944) Amphetamines [Presence] in Urine

339

2657

1.29

4.74

2.1

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

728

6204

1.19

4.69

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

609

1.60

4.67

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

171

2.17

4.67

1.1

93.13

86.45

0.63

(3004451) EKG impression Narrative

245

1.97

4.67

1.2

—

(3017732) Neutrophils [#/volume] in Blood

464

3794

1.24

4.55

3.7

2.8

6.12

4.93

e9/l

0.56

385

3128

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

430

1.70

4.51

2.4

2.0

1.35

1.69

u/field

0.38

179

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

237

1783

1.34

4.47

3.6

3.5

733.79

3451.44

u/ml

0.98

208

1536

(3024263) Appearance of Synovial fluid

306

1.84

4.46

1.2

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

588

1.59

4.38

1.5

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

360

2875

1.27

4.36

2.1

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

163

1159

1.42

4.35

2.9

2.3

0.92

0.81

nmol/l

1.54

147

972

(3040893) Potassium [Moles/volume] in Capillary blood

7.51

4.35

3.7

1.8

4.30

4.58

mmol/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

259

1.90

4.33

2.2

2.4

51.30

51.58

umol/l

0.02

228

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

190

2.06

4.33

2.5

2.8

25.22

28.19

umol/l

0.76

138

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

138

2.25

4.30

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

607

1.57

4.28

1.9

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

246

1.92

4.28

1.6

1.8

163.78

149.87

0.53

237

(3008401) Mugwort IgE Ab [Units/volume] in Serum

152

1072

1.43

4.26

1.1

0.90

1.38

u/ml

0.70

471

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

120

2.34

4.23

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

609

1.57

4.23

1.9

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

312

1.80

4.21

1.3

1.1

1.06

1.04

ratio

0.47

102

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

603

1.57

4.18

1.9

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

604

1.56

4.15

1.9

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.24

4.13

1.3

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

167

2.10

4.12

1.1

1.2

92.59

86.06

0.45

(3013293) Extractable nuclear Ab [Presence] in Serum

2.80

4.11

1.6

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

286

1.82

4.09

1.6

1.5

5.26

6.46

u/l

0.26

233

(3014133) Dog dander IgE Ab [Units/volume] in Serum

125

860

1.46

4.01

1.1

1.0

7.01

3.12

u/ml

1.83

412

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.20

4.00

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

245

1.88

4.00

3.5

3.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

5.56

3.97

1.0

—

(3021788) Differential panel - Synovial fluid

137

962

1.43

3.96

1.6

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

326

1.75

3.95

1.9

1.4

5.55

6.37

u/l

0.55

280

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

644

1.53

3.94

3.2

2.2

32.32

32.63

0.28

637

(3025468) Yersinia sp identified in Specimen by Organism specific culture

605

1.54

3.91

1.9

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.79

3.88

2.4

3.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.77

3.84

1.4

19.28

26.32

0.42

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

474

1.61

3.83

1.8

1.5

30.16

27.47

0.25

293

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

415

3427

1.22

3.76

1.3

1.2

122.75

147.39

iu/ml

0.68

162

1263

(3010838) Calcium [Moles/time] in 24 hour Urine

121

839

1.45

3.76

2.0

1.8

5.14

4.98

mmol/24h

0.19

105

739

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.59

3.74

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

5.63

3.65

1.6

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.00

3.59

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

475

1.59

3.58

1.6

1.3

15217.20

116695.54

e6/l

2.66

328

(3016038) Potassium [Moles/volume] in Urine

329

1.71

3.57

1.3

34.86

35.15

mmol/l

0.03

289

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

436

3639

1.21

3.57

2.2

2.0

—

(3011985) Renin [Units/volume] in Plasma

102

694

1.48

3.52

1.5

72.31

63.66

mu/l

0.15

616

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

235

1.83

3.50

2.5

2.3

154.68

149.16

nmol/l

0.12

202

(3016135) IgD [Mass/volume] in Serum

6.16

3.50

1.3

1.0

67.24

59.22

mg/l

—

(21494755) Public health laboratory ask at order entry panel

587

6806

0.85

3.49

1.3

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.88

3.48

1.2

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.70

3.48

1.8

3.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

165

2.00

3.48

1.9

2.0

4376.75

15825.27

e6/l

0.51

(44816559) Phosphatidylethanol [Mass/volume] in Blood

161

1192

1.36

3.46

1.5

1.4

—

(3018133) Calcium [Moles/volume] in Urine

100

2.30

3.42

2.4

3.10

2.40

mmol/l

0.62

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

160

2.00

3.38

8.3

6.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

374

1.64

3.34

2.9

2.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

313

1.70

3.34

1.7

1.5

1.32

1.15

nmol/l

0.57

244

(3014051) Protein [Presence] in Urine by Test strip

175

1324

1.33

3.28

3.1

2.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

392

3268

1.21

3.27

1.2

—

(3020491) Glucose [Moles/volume] in Blood

409

1.59

3.22

3.5

1.9

7.90

6.67

mmol/l

1.26

274

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

349

1.64

3.16

1.4

1.5

27.33

26.15

u/ml

0.05

(40761539) Cells [Type] in Urine sediment by Light microscopy

125

2.08

3.07

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

188

1.87

3.04

2.0

2.2

420.19

771.35

e6/l

1.27

140

(3042517) Benzodiazepines panel - Urine

2.58

3.04

1.8

2.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2352

22164

1.09

3.01

3.9

4.4

2.47

2.89

ug/l

0.46

2163

20126

(3044007) Cell count panel - Peritoneal fluid

147

1.98

2.99

2.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.24

2.95

1.1

0.17

0.58

u/ml

1.28

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.54

2.95

4.0

9.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1487

13726

1.11

2.94

1.7

1.6

1.59

1.41

mmol/l

5.42

1314

11716

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

364

1.60

2.94

1.8

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.71

2.91

3.9

5.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.44

2.89

7.3

3.6

—

(3051611) Lipemic interference index of Serum or Plasma

543

1.48

2.86

4.0

3.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

704

6234

1.14

2.84

2.2

2.0

—

(40768804) Tissue Pathology biopsy report

2221

20922

1.09

2.83

2.2

2.0

—

(4035726) Immunohistochemistry procedure

504

4356

1.17

2.83

1.5

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

306

1.64

2.81

1.8

2.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

201

1.80

2.80

1.2

—

(3049717) Cytology report of Urine Cyto stain

241

1945

1.25

2.79

2.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

276

1.67

2.79

1.7

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.55

2.78

1.2

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5678

55640

1.10

2.77

4.7

4.6

2.68

2.77

mmol/l

12.82

5354

51895

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

771

6881

1.14

2.76

2.3

2.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.27

2.76

1.3

1.6

19.00

7.83

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

239

1.72

2.76

1.1

90.55

96.54

0.66

190

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

378

1.57

2.76

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

632

1.43

2.72

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1673

15591

1.10

2.70

1.5

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

153

1.90

2.69

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

445

1.51

2.68

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

112

2.06

2.66

1.4

1.1

85.60

79.58

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

154

1.89

2.65

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

235

1.71

2.64

2.8

2.0

30.93

27.89

umol/l

0.57

225

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

397

3387

1.18

2.63

1.3

39.19

55.63

au/ml

0.95

183

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.93

2.61

5.3

5.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

408

1.52

2.60

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

656

1.41

2.57

1.4

324.68

472.23

pmol/l

0.45

561

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

431

3713

1.17

2.55

2.4

2.3

13.70

22.57

au/ml

2.90

320

(40758292) HTLV I+II Ab panel - Serum

101

2.08

2.52

1.7

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.23

2.51

5.5

7.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.16

2.50

1.2

1.1

—

6.68

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

173

1363

1.28

2.49

2.3

147.55

130.04

ug/min

0.19

119

866

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.13

2.43

1.2

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

280

1.61

2.42

1.4

1.3

136.65

134.98

nmol/l

0.08

280

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.00

2.40

4.2

8.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5583

54762

1.09

2.40

4.4

4.2

4.50

4.63

mmol/l

17.74

5296

51378

(3034891) Synovial lining cells/100 cells in Synovial fluid

242

1.66

2.40

1.7

1.5

2.09

4.44

0.75

(3004716) Salmonella sp identified in Stool by Organism specific culture

330

2797

1.19

2.39

1.4

1.3

—

(40768443) Skin Pathology biopsy report

265

2201

1.21

2.39

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

281

1.61

2.39

2.5

1.6

1.78

3.24

u/field

0.79

212

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

175

2190

0.79

2.39

1.5

—

(40763590) HLA-DQ beta [Type]

3.64

2.36

1.0

—

(40760409) HLA-A [Type] by High resolution

3.64

2.36

1.0

—

(40760410) HLA-B [Type] by High resolution

3.64

2.36

1.0

—

(3013862) HLA-DP [Type]

3.64

2.36

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.64

2.36

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

104

2.02

2.35

1.1

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

118

1.95

2.34

3.0

2.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.94

2.28

3.6

3.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

178

1.74

2.25

1.1

1.71

19.86

u/ml

0.50

102

(3002331) Protein [Mass/volume] in Peritoneal fluid

113

1.95

2.24

1.4

24.06

23.75

g/l

0.03

(3008898) HLA-B27 [Presence]

234

1935

1.22

2.23

1.1

—

(3032641) Amino acids panel - Urine

5.56

2.21

1.4

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.56

2.21

1.4

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

103

1364

0.75

2.21

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

359

1.51

2.21

1.7

1.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.86

2.20

4.4

3.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

225

1.65

2.20

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

114

1.93

2.20

1.5

1.2

83.89

73.05

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5364

52586

1.08

2.18

4.0

3.8

1.42

1.33

mmol/l

10.76

5037

48797

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.13

2.18

1.2

30.50

59.68

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.02

2.15

1.8

1.5

0.35

0.38

ug/l

0.22

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1266

0.75

2.14

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1174

0.74

2.13

1.4

—

(40761536) Microorganisms panel - Urine sediment

508

4495

1.14

2.13

5.3

3.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

254

2128

1.20

2.13

1.5

1.6

306.82

292.45

mu/l

0.25

228

1945

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

220

1.64

2.11

1.0

1.1

9.40

10.09

u/ml

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

167

1342

1.25

2.10

2.0

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

735

1.34

2.08

1.1

1.0

0.46

0.56

u/ml

0.14

199

(3043410) Blood group antigens tested for on Red Blood Cells

153

1.77

2.07

2.0

1.7

—

(40762887) Creatinine [Moles/volume] in Blood

5.00

2.07

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

168

1.73

2.07

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.08

2.06

1.2

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1177

0.74

2.05

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

222

1.62

2.05

11.2

13.4

—

(3032057) Clostridioides difficile [Presence] in Stool

1.98

2.05

2.0

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.18

2.04

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1176

0.75

2.04

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1175

0.75

2.03

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.40

2.02

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

147

1.77

2.01

8.4

6.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.08

2.01

9.6

4.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1001

0.73

2.01

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

385

1.46

1.98

1.1

—

(40768795) Lymph node Pathology biopsy report

460

1.42

1.97

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

669

0.67

1.95

1.1

1.4

170.24

188.09

pmol/l

0.39

669

(3020874) Milk IgE Ab [Units/volume] in Serum

370

1.46

1.95

1.1

3.91

1.43

u/ml

0.92

120

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

4.55

1.94

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

379

1.45

1.93

1.1

2.98

3.13

u/ml

0.03

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

371

1.46

1.92

1.6

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

388

1.45

1.91

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.18

1.88

5.0

3.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

602

1.35

1.86

2.7

2.0

18.00

23.50

mg/l

0.75

155

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

121

953

1.27

1.84

1.1

61.77

602.12

iu/ml

0.52

237

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.12

1.81

1.0

1.1

0.04

0.23

u/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

638

5789

1.11

1.80

2.6

2.2

13.01

13.18

nmol/l

0.21

573

5277

(3013637) Mi-2 Ab [Presence] in Serum

123

1.79

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

123

1.79

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

123

1.79

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

123

1.79

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

153

1.70

1.79

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

539

1.36

1.76

2.3

2.5

18.15

19.30

nmol/l

0.50

514

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.34

1.74

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

363

1.44

1.74

1.4

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

170

1.65

1.73

1.1

1.2

107.96

107.97

0.00

146

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.67

1.72

1.0

1.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.13

1.71

1.0

—

(3005033) Fetal Nuchal fold Thickness US

961

0.75

1.71

1.5

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

118

1.78

1.69

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

235

1.53

1.67

1.2

1.3

168.72

170.08

mmol/24h

0.03

235

(3033923) Metanephrine [Moles/time] in 24 hour Urine

104

1.83

1.67

1.1

1.2

0.82

0.68

umol/24h

—

(3004616) Nuclear Ab [Presence] in Serum

606

1.32

1.65

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.98

1.64

1.1

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

965

0.75

1.63

1.5

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

181

1.60

1.62

1.1

1.2

0.32

0.30

g/l

0.77

145

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

237

2033

1.17

1.59

3.8

3.0

48.21

54.49

u/ml

0.27

227

1966

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1225

13015

0.93

1.59

2.5

2.8

0.68

0.74

ug/l

0.67

739

7908

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.95

1.59

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

119

1473

0.80

1.58

1.4

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.11

1.54

1.0

1.2

13.08

10.36

mg/l

0.26

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.03

1.54

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.03

1.54

1.5

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.33

1.52

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

115

1.74

1.52

1.5

1.3

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.59

1.51

1.1

0.71

0.57

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.00

1.51

0.0

1.2

—

2.21

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

185

1.57

1.51

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

750

1.27

1.48

1.5

1.4

23.04

21.93

u/l

0.13

624

(3015076) Soybean IgE Ab [Units/volume] in Serum

343

1.40

1.46

1.0

0.98

1.48

u/ml

0.21

(3048879) Bone marrow aspiration report

132

1.67

1.45

3.5

1.9

—

(3036048) Francisella tularensis Ab [Titer] in Serum

132

1.67

1.45

1.0

1.2

—

360.00

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

386

1.38

1.44

1.7

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

412

1.36

1.44

1.1

—

(3007463) Buprenorphine [Presence] in Urine

2.73

1.43

3.7

7.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

551

1.31

1.43

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

204

1.52

1.42

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5514

54370

1.06

1.40

4.3

4.1

1.34

1.40

mmol/l

25.04

5211

50772

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.42

1.39

1.0

1.8

—

(3022475) Manganese [Moles/volume] in Blood

2.42

1.39

1.1

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.08

1.38

6.0

3.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.94

1.38

1.9

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

485

1.32

1.37

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

124

1020

1.22

1.36

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

124

1022

1.22

1.34

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

592

1.29

1.34

2.4

3.2

5.53

15.22

nmol/l

0.53

582

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

208

0.53

1.32

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

192

1.51

1.31

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

121

1.65

1.30

1.1

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.09

1.30

1.1

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

490

1.31

1.29

1.3

1.2

43.24

41.88

mg/l

0.09

404

(40768441) Liver Pathology biopsy report

386

1.35

1.29

1.3

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

228

1989

1.15

1.29

1.6

1.7

—

(3044927) Protein electrophoresis panel - Urine

499

1.31

1.29

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

114

1.67

1.28

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

327

1.38

1.27

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

293

2603

1.13

1.27

1.2

1.1

784.50

176.75

titre

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

252

1.43

1.25

2.8

2.4

—

(40765096) Chromosome analysis panel by Banding

146

1.58

1.25

1.4

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.40

1.24

1.2

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.40

1.24

1.5

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

476

1.31

1.24

1.2

1.1

269.98

273.32

mg/l

0.04

414

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.63

1.21

1.4

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.63

1.21

1.2

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

297

1.38

1.19

1.1

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.83

1.19

1.2

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

182

2097

0.86

1.17

1.6

1.7

8.59

4.12

mg/l

1.90

139

1510

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.93

1.16

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.00

1.16

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.00

1.16

1.0

1.1

—

(3013762) Body weight Measured

0.00

1.16

0.0

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.50

1.15

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

150

1.54

1.14

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

335

1.35

1.13

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

175

1.49

1.12

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.90

1.12

1.4

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

458

1.29

1.11

1.1

1.0

299.65

279.59

mg/l

1.15

419

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

151

1.52

1.11

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

488

1.27

1.06

1.2

324.68

364.28

nmol/l

0.84

430

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

1.49

1.06

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

340

1.33

1.04

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

254

1.38

1.04

2.4

1.7

2.48

15.19

nmol/l

0.73

208

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.96

1.03

1.6

2.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.63

1.03

1.9

3.0

12.86

24.14

mg/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.06

1.02

1.3

1.2

—

(3007916) DNA double strand Ab [Titer] in Serum

1.89

1.01

2.1

1.5

—

158.65

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.89

1.01

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

827

1.20

1.00

1.1

4.56

3.26

u/ml

0.28

407

(3011544) Albumin [Mass/volume] in Pleural fluid

1.88

1.00

1.4

1.1

16.50

16.98

g/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.88

1.00

1.1

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

222

1.40

1.00

1.1

108.36

146.33

ng/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.00

1.00

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.17

0.98

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.67

0.97

1.9

1.7

77.66

139.49

ng/l

2.53

(1002224) Polysomnography panel

296

2687

1.11

0.94

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

1.77

0.94

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.72

0.92

1.9

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

192

1.41

0.92

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

146

1671

0.87

0.91

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

636

5978

1.07

0.90

1.6

1.7

—

(3000285) Sodium [Moles/volume] in Blood

1.69

0.88

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

160

1.44

0.88

1.1

—

(3004775) Volume in Urine collected for unspecified duration

439

1.25

0.88

2.1

2.3

691.39

661.56

0.21

301

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.00

0.87

1.0

0.03

0.58

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

161

1.43

0.86

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

704

1.20

0.86

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.78

0.84

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.69

0.82

1.1

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

214

1.36

0.82

1.1

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

283

0.71

0.80

1.5

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.82

0.79

1.5

1.2

18.17

12.55

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.67

0.78

1.7

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

776

1.17

0.78

1.5

0.33

0.40

nmol/l

0.48

645

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

133

1168

1.14

0.78

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

134

1521

0.88

0.78

1.1

—

(3020650) Glucose [Presence] in Urine

162

0.62

0.76

1.9

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.70

0.75

1.1

1.2

2.14

1.68

umol/24h

—

(3006462) Nitrate [Presence] in Urine

235

1.32

0.75

2.9

3.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.60

0.74

1.3

1.9

19.85

48.34

pmol/l

1.75

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

315

1.27

0.74

1.1

0.96

1.08

u/l

1.09

150

(3041672) Baker's yeast Ab [Presence] in Serum

1.84

0.73

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.67

0.72

1.1

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

326

1.26

0.71

5.1

7.2

49.13

8193.20

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

117

1.45

0.71

8.1

6.8

—

(3002256) Pathology report gross observation

701

6670

1.06

0.71

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.92

0.70

1.0

1.2

273.80

231.28

nmol/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

143

1.40

0.70

1.2

1.3

256.94

291.43

ug/l

0.04

(3001556) Androgen free Index in Serum or Plasma

1.55

0.69

1.1

1.2

—

(40768793) Breast Pathology biopsy report

868

0.85

0.69

1.2

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

211

1923

1.10

0.68

1.5

1.4

8.78

7.91

u/l

0.40

170

1567

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.85

0.68

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.64

0.68

4.5

2.2

0.70

0.57

u/field

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.56

0.68

3.3

2.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1833

17848

1.04

0.67

3.5

3.8

21.90

21.76

0.13

728

7861

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

197

1792

1.10

0.67

2.0

1.9

204.80

204.07

pmol/l

0.03

189

1707

(3001019) Free T4 and TSH panel - Serum or Plasma

283

3055

0.92

0.66

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

1.79

0.66

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.57

0.65

1.0

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.72

0.64

1.0

1.1

—

23.61

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

635

1.17

0.63

1.8

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

617

1.17

0.62

2.2

5.64

9.41

umol/l

1.43

440

(3038177) Helicobacter pylori Ab [Presence] in Serum

110

973

1.13

0.62

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

480

1.19

0.61

3.4

5.0

131.17

53.39

u/ml

0.41

144

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

122

1.39

0.60

1.1

76.84

64.47

u/ml

0.27

116

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

378

0.79

0.59

1.4

1.3

1.50

1.53

g/l

0.25

378

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

611

1.16

0.59

1.4

1.3

—

nmol/l

—

(3016750) Collection duration of Urine

326

1.23

0.59

2.0

2.2

501.81

496.21

min

0.13

251

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.59

0.0

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

304

2838

1.07

0.59

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.43

0.56

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.62

0.55

1.2

22.17

19.46

u/l

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

168

1.31

0.54

1.0

8.04

13.01

u/ml

—

106

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.58

0.54

2.5

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

692

1.14

0.54

1.4

1.3

0.19

0.27

nmol/l

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.48

0.53

11.9

6.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

646

1.15

0.53

1.4

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

117

1.37

0.52

1.1

1.2

264.20

282.87

pmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

620

1.15

0.51

1.4

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.41

0.51

1.9

2.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.41

0.51

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

292

0.79

0.50

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.43

0.49

4.8

1.4

6.76

8.26

mmol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

454

0.84

0.49

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.56

0.48

1.0

1.2

—

34.08

—

(3051101) Glucose [Moles/volume] in Cord blood

1.40

0.48

4.1

6.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

291

1.20

0.46

1.3

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

246

1.22

0.45

2.9

3.8

9.40

8.34

mg/l

0.40

202

(3001729) Color of Synovial fluid

1.40

0.45

1.4

1.2

—

(3033799) Differential panel - Peritoneal fluid

165

1.27

0.44

1.7

2.0

—

(3002619) Bacteria identified in Specimen by Culture

112

1.34

0.44

1.7

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

1.31

0.43

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.61

0.43

1.0

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

149

1.28

0.41

1.5

7.67

8.40

ug/l

0.38

149

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.52

0.41

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.52

0.41

1.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.41

0.0

1.2

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

15.38

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.47

0.40

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.31

0.39

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

130

1200

1.08

0.39

5.7

3.3

34.44

27.01

mg/l

1.48

758

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.32

0.37

1.1

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.35

0.37

1.2

—

(3015183) Erythrocyte sedimentation rate

322

0.84

0.37

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.29

0.36

1.9

2.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.66

0.35

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.37

0.34

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.36

0.34

1.5

2.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

471

1.13

0.34

1.2

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

182

1.21

0.33

1.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.67

0.33

1.2

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

165

1.21

0.31

1.9

1.5

95.95

134.72

nmol/24h

0.45

165

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

916

1.08

0.31

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

286

1.15

0.31

1.5

—

(3019225) pH of Specimen

471

4867

0.97

0.30

6.1

4.2

—

(4281824) Cell count and differential, peritoneal fluid

442

0.88

0.30

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.29

0.30

1.0

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

196

0.82

0.29

1.9

3.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

163

0.80

0.29

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

195

0.82

0.28

3.8

6.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.27

0.27

1.3

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

260

2495

1.04

0.27

1.4

24.04

23.52

iu/l

0.09

217

2119

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

215

1.16

0.26

1.0

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

110

1032

1.07

0.26

2.9

3.6

239.21

757.42

u/ml

1.08

955

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

252

2421

1.04

0.25

1.8

38.28

39.52

nmol/l

0.39

247

2362

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

319

0.88

0.25

3.4

2.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

264

1.14

0.24

2.5

2.1

132.20

211.24

ug/min

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.26

0.24

3.3

5.2

51.00

43.89

ug/min

0.24

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.17

0.24

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

629

6432

0.98

0.23

10.6

6.8

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.32

0.23

6.6

3.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

111

1049

1.06

0.22

1.7

1.5

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.21

0.0

1.0

—

841.09

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

780

0.94

0.20

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.20

0.0

1.0

—

(40758358) Immune stain study

0.00

0.20

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.20

0.0

2.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.20

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.20

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.20

0.0

2.0

—

(3008607) Semen analysis panel

1.25

0.20

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

281

0.89

0.19

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

327

1.10

0.19

1.0

816.21

751.31

ng/l

0.30

221

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

109

1.19

0.18

1.5

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

328

1.10

0.18

1.0

35.23

43.77

ng/l

0.75

226

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.19

0.18

1.3

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

775

1.06

0.18

1.2

1.3

7.92

7.25

mmol/l

1.16

690

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

329

1.09

0.17

1.0

217.16

312.94

ng/l

2.96

230

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

213

0.89

0.15

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

304

1.09

0.14

5.2

7.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

132

1.14

0.13

1.6

1.8

—

(4146454) Self-monitoring of blood glucose

530

1.06

0.13

2.6

2.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

123

1.14

0.12

2.2

6.5

72.44

73.67

—

101

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

167

0.90

0.10

2.1

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

666

6733

0.99

0.10

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.06

0.09

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

812

1.03

0.09

3.4

2.4

13.36

13.11

1.33

800

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

909

0.97

0.09

1.5

1.4

117.64

156.14

pmol/l

0.38

888

(3032868) Hemoglobin electrophoresis panel in Blood

0.79

0.08

1.6

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.03

0.07

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

205

1.07

0.07

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.02

0.07

2.4

2.2

—

(3025130) Human papilloma virus identified in Specimen

546

0.97

0.05

1.5

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

149

1.07

0.05

1.2

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

120

1.08

0.04

3.9

2.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

278

1.04

0.04

1.3

1.1

1436.31

1512.81

miu/ml

0.16

278

(3025577) Chromium [Mass/volume] in Blood

288

0.97

0.02

1.9

2.1

2.58

2.10

ug/l

0.22

241

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

141

1417

0.99

0.00

1.5

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

100

1.00

0.00

1.0

—

(3039528) Macrophages/100 leukocytes in Pleural fluid by Manual count

0.00

0.0

3.8

—

29.80

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.40

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.8

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.01

-0.00

1.0

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

0.95

-0.00

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1306.25

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

2.1

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.1

—

30.00

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.91

-0.00

1.2

1.3

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_ACUTELOWERNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_ACUTELOWERNAS	2.522 [2.2, 2.9]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.044

During the follow-up period (1.1.1998 — 31.12.2019), 5097 out of 15402 females with J10_ACUTELOWERNAS died.

Males

Parameter	HR [95% CI]	p-value
J10_ACUTELOWERNAS	2.888 [2.44, 3.42]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.022

During the follow-up period (1.1.1998 — 31.12.2019), 5409 out of 15571 males with J10_ACUTELOWERNAS died.

Mortality risk

Mortality risk for people of age

years, who have J10_ACUTELOWERNAS.

N-year risk	Females	Males
1	0.221%	0.55%
5	1.399%	3.759%
10	3.403%	8.868%
15	5.952%	16.599%
20	10.755%	27.09%

Relationships between endpoints

↥

Index endpoint: J10_ACUTELOWERNAS – Unspecified acute lower respiratory infection

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Unspecified acute lower respiratory infection

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints